,path_name,adj_p_val,overlapping_genes,mode
0,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),4.056177465354193e-06,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",1
1,cytoplasmic translation (GO:0002181),4.056177465354193e-06,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",1
2,cotranslational protein targeting to membrane (GO:0006613),4.056177465354193e-06,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",1
3,protein targeting to ER (GO:0045047),4.824395942323014e-06,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",1
4,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",6.149757368207969e-06,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",1
5,antigen processing and presentation of endogenous peptide antigen (GO:0002483),2.075835383429735e-05,"['HLA-DRA', 'B2M', 'HLA-E']",1
6,peptide biosynthetic process (GO:0043043),2.651346263499792e-05,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",1
7,nuclear-transcribed mRNA catabolic process (GO:0000956),3.032944450555642e-05,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",1
8,translation (GO:0006412),8.15190984158129e-05,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",1
9,positive regulation of T cell mediated immunity (GO:0002711),0.00024091506002521792,"['HLA-DRA', 'B2M', 'HLA-E']",1
10,cellular macromolecule biosynthetic process (GO:0034645),0.0004324206914632178,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",1
11,gene expression (GO:0010467),0.0007258886374571986,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",1
12,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.0008216333077943834,"['B2M', 'HLA-E']",1
13,interferon-gamma-mediated signaling pathway (GO:0060333),0.0011430504026425684,"['HLA-DRA', 'B2M', 'HLA-E']",1
14,sequestering of actin monomers (GO:0042989),0.0011430504026425684,"['TMSB4X', 'TMSB10']",1
15,cellular protein metabolic process (GO:0044267),0.0011599573224752842,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",1
16,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.0033634340588045153,"['CD74', 'HLA-DRA', 'HLA-E']",1
17,positive regulation of alpha-beta T cell activation (GO:0046635),0.0039978374414207036,"['HLA-DRA', 'HLA-E']",1
18,cellular response to interferon-gamma (GO:0071346),0.004844517655625386,"['HLA-DRA', 'B2M', 'HLA-E']",1
19,negative regulation of actin filament polymerization (GO:0030837),0.0055749844187833525,"['TMSB4X', 'TMSB10']",1
20,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.0055749844187833525,"['CD74', 'TPT1']",1
21,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.0055749844187833525,"['HLA-DRA', 'HLA-E']",1
22,regulation of T cell mediated cytotoxicity (GO:0001914),0.006649677580675513,"['HLA-DRA', 'HLA-E']",1
23,negative regulation of response to DNA damage stimulus (GO:2001021),0.007289935890371812,"['CD74', 'TPT1']",1
24,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.007631715723842814,"['B2M', 'HLA-E']",1
25,positive regulation of cytokine production involved in immune response (GO:0002720),0.007631715723842814,"['B2M', 'HLA-E']",1
26,rRNA metabolic process (GO:0016072),0.008021192330621423,"['RPL11', 'RPS6', 'RPL19']",1
27,retina homeostasis (GO:0001895),0.00844041045557364,"['B2M', 'ACTG1']",1
28,regulation of cell migration (GO:0030334),0.008740707987258393,"['CD74', 'TMSB4X', 'TMSB10', 'ACTG1']",1
29,rRNA processing (GO:0006364),0.008740707987258393,"['RPL11', 'RPS6', 'RPL19']",1
30,regulation of immune response (GO:0050776),0.009339446819772883,"['HLA-DRA', 'B2M', 'HLA-E']",1
31,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.01054138462446233,"['HLA-DRA', 'HLA-E']",1
32,ribosome biogenesis (GO:0042254),0.01075010788304791,"['RPL11', 'RPS6', 'RPL19']",1
33,ncRNA processing (GO:0034470),0.011910992822433969,"['RPL11', 'RPS6', 'RPL19']",1
34,positive regulation of protein binding (GO:0032092),0.017484903908341457,"['RPL11', 'B2M']",1
35,ribonucleoprotein complex biogenesis (GO:0022613),0.018180638908410807,"['RPL11', 'RPS6']",1
36,protein tetramerization (GO:0051262),0.02467193914976852,"['B2M', 'MS4A1']",1
37,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.025374677831777933,"['B2M', 'HLA-E']",1
38,positive regulation of immune response (GO:0050778),0.02542388766475268,"['CD74', 'HLA-DRA']",1
39,positive regulation of lymphocyte proliferation (GO:0050671),0.02542388766475268,"['CD74', 'HLA-E']",1
40,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.02679358313489366,"['B2M', 'HLA-E']",1
41,regulation of interleukin-8 production (GO:0032677),0.028118156496156854,"['CD74', 'TMSB4X']",1
42,cytokine-mediated signaling pathway (GO:0019221),0.028118156496156854,"['TMSB4X', 'HLA-DRA', 'B2M', 'HLA-E']",1
43,innate immune response (GO:0045087),0.029420092283025306,"['CD74', 'B2M', 'HLA-E']",1
44,positive regulation of binding (GO:0051099),0.03232448248186749,"['RPL11', 'B2M']",1
45,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.03724347408275035,"['CD74', 'HLA-DRA']",1
46,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.03724347408275035,"['CD74', 'HLA-DRA']",1
47,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",0.03724347408275035,['HLA-DRA'],1
48,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026),0.03724347408275035,['TMSB4X'],1
49,positive regulation of natural killer cell proliferation (GO:0032819),0.03724347408275035,['HLA-E'],1
50,cellular response to nicotine (GO:0071316),0.03724347408275035,['B2M'],1
51,positive regulation of prostaglandin biosynthetic process (GO:0031394),0.03724347408275035,['CD74'],1
52,tight junction organization (GO:0120193),0.03724347408275035,['ACTG1'],1
53,regulation of natural killer cell mediated immunity (GO:0002715),0.03724347408275035,['HLA-E'],1
54,calcium ion transport (GO:0006816),0.038533401991162425,"['MS4A1', 'TPT1']",1
55,regulation of T-helper cell differentiation (GO:0045622),0.038533401991162425,['HLA-DRA'],1
56,regulation of type 2 immune response (GO:0002828),0.038533401991162425,['CD74'],1
57,cellular response to iron ion (GO:0071281),0.038533401991162425,['B2M'],1
58,positive regulation of receptor binding (GO:1900122),0.038533401991162425,['B2M'],1
59,peptide antigen assembly with MHC protein complex (GO:0002501),0.038533401991162425,['HLA-DRA'],1
60,protection from natural killer cell mediated cytotoxicity (GO:0042270),0.038533401991162425,['HLA-E'],1
61,regulation of protein binding (GO:0043393),0.038533401991162425,"['RPL11', 'B2M']",1
62,positive regulation of macromolecule metabolic process (GO:0010604),0.038533401991162425,"['CD74', 'RPL11', 'ACTG1']",1
63,positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.038533401991162425,['CD74'],1
64,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.038533401991162425,['HLA-E'],1
65,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.038533401991162425,['HLA-E'],1
66,response to host defenses (GO:0052200),0.038533401991162425,['B2M'],1
67,positive regulation of natural killer cell cytokine production (GO:0002729),0.038533401991162425,['HLA-E'],1
68,positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),0.038533401991162425,['CD74'],1
69,regulation of natural killer cell cytokine production (GO:0002727),0.038533401991162425,['HLA-E'],1
70,regulation of natural killer cell proliferation (GO:0032817),0.038533401991162425,['HLA-E'],1
71,modulation by symbiont of host defense response (GO:0052031),0.038533401991162425,['B2M'],1
72,regulation of prostaglandin biosynthetic process (GO:0031392),0.038533401991162425,['CD74'],1
73,regulation of cell motility (GO:2000145),0.03966990957091606,"['TMSB4X', 'TMSB10']",1
74,"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.03966990957091606,['HLA-DRA'],1
75,alpha-beta T cell activation (GO:0046631),0.03966990957091606,['HLA-E'],1
76,antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.03966990957091606,['B2M'],1
77,"regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.03966990957091606,['HLA-DRA'],1
78,"regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.03966990957091606,['HLA-E'],1
79,store-operated calcium entry (GO:0002115),0.03966990957091606,['MS4A1'],1
80,cytoplasmic sequestering of NF-kappaB (GO:0007253),0.03966990957091606,['TMSB4X'],1
81,regulation of intracellular signal transduction (GO:1902531),0.040146741322399135,"['TMSB4X', 'RPL11', 'DDIT4']",1
82,positive regulation of ATP biosynthetic process (GO:2001171),0.040146741322399135,['TMSB4X'],1
83,regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.040146741322399135,['TMSB4X'],1
84,"positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.040146741322399135,['HLA-E'],1
85,"regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.040146741322399135,['HLA-E'],1
86,positive regulation of ligase activity (GO:0051351),0.040146741322399135,['TMSB4X'],1
87,positive regulation of macrophage cytokine production (GO:0060907),0.040146741322399135,['CD74'],1
88,positive regulation of memory T cell differentiation (GO:0043382),0.040146741322399135,['HLA-DRA'],1
89,negative regulation of ubiquitin protein ligase activity (GO:1904667),0.040146741322399135,['RPL11'],1
90,regulation of receptor binding (GO:1900120),0.04053303830937007,['B2M'],1
91,immunoglobulin mediated immune response (GO:0016064),0.04053303830937007,['CD74'],1
92,positive regulation of monocyte differentiation (GO:0045657),0.04053303830937007,['CD74'],1
93,negative regulation of receptor binding (GO:1900121),0.04053303830937007,['B2M'],1
94,regulation of memory T cell differentiation (GO:0043380),0.04053303830937007,['HLA-DRA'],1
95,positive regulation of viral entry into host cell (GO:0046598),0.04053303830937007,['CD74'],1
96,modulation by symbiont of host process (GO:0044003),0.04053303830937007,['B2M'],1
97,positive regulation by symbiont of entry into host (GO:0075294),0.04053303830937007,['CD74'],1
98,regulation of protein neddylation (GO:2000434),0.04053303830937007,['RPL11'],1
99,B cell mediated immunity (GO:0019724),0.04325446294363687,['CD74'],1
100,positive regulation of interleukin-13 production (GO:0032736),0.04325446294363687,['HLA-E'],1
101,negative regulation of natural killer cell mediated immunity (GO:0002716),0.04325446294363687,['HLA-E'],1
102,positive regulation of gene expression (GO:0010628),0.044770588527761675,"['CD74', 'RPL11', 'ACTG1']",1
103,negative regulation of cell division (GO:0051782),0.044770588527761675,['TXNIP'],1
104,positive regulation of cellular senescence (GO:2000774),0.044770588527761675,['B2M'],1
105,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.044770588527761675,['HLA-DRA'],1
106,morphogenesis of a polarized epithelium (GO:0001738),0.044770588527761675,['ACTG1'],1
107,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.044770588527761675,['HLA-DRA'],1
108,positive regulation of cell aging (GO:0090343),0.044770588527761675,['B2M'],1
109,regulation of actomyosin structure organization (GO:0110020),0.044770588527761675,['ACTG1'],1
110,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.044770588527761675,['CD74'],1
111,response to iron ion (GO:0010039),0.044770588527761675,['B2M'],1
112,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.044770588527761675,['CD74'],1
113,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.044770588527761675,['BTG2'],1
114,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.044770588527761675,['TMSB4X'],1
115,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.044770588527761675,['CD74'],1
116,negative regulation of secretion (GO:0051048),0.044770588527761675,['CD74'],1
117,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.044770588527761675,['CD74'],1
118,positive regulation of regulatory T cell differentiation (GO:0045591),0.044770588527761675,['HLA-DRA'],1
119,regulation of macrophage cytokine production (GO:0010935),0.044770588527761675,['CD74'],1
120,cytoplasmic sequestering of transcription factor (GO:0042994),0.044770588527761675,['TMSB4X'],1
121,positive regulation of type 2 immune response (GO:0002830),0.044770588527761675,['CD74'],1
122,antigen receptor-mediated signaling pathway (GO:0050851),0.044770588527761675,"['HLA-DRA', 'MS4A1']",1
123,positive regulation of endothelial cell chemotaxis (GO:2001028),0.044770588527761675,['TMSB4X'],1
124,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.044770588527761675,['HLA-E'],1
125,calcium ion import into cytosol (GO:1902656),0.044770588527761675,['MS4A1'],1
126,regulation of endothelial cell chemotaxis (GO:2001026),0.044770588527761675,['TMSB4X'],1
127,positive regulation of natural killer cell activation (GO:0032816),0.044770588527761675,['HLA-E'],1
128,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.044770588527761675,['RPL11'],1
129,positive regulation of response to cytokine stimulus (GO:0060760),0.044770588527761675,['CD74'],1
130,neurotrophin TRK receptor signaling pathway (GO:0048011),0.044770588527761675,['DDIT4'],1
131,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.044770588527761675,['BTG2'],1
132,prostanoid biosynthetic process (GO:0046457),0.044770588527761675,['CD74'],1
133,protein localization to cell-cell junction (GO:0150105),0.044770588527761675,['ACTG1'],1
134,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.044770588527761675,['HLA-E'],1
135,regulation of ATP biosynthetic process (GO:2001169),0.044770588527761675,['TMSB4X'],1
136,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.044770588527761675,['HLA-E'],1
137,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.044770588527761675,['CD74'],1
138,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.044770588527761675,['TMSB4X'],1
139,regulation of interleukin-13 production (GO:0032656),0.044770588527761675,['HLA-E'],1
140,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.044770588527761675,['TPT1'],1
141,regulation of leukocyte activation (GO:0002694),0.044770588527761675,['CD74'],1
142,regulation of monocyte differentiation (GO:0045655),0.044770588527761675,['CD74'],1
143,negative regulation of intracellular signal transduction (GO:1902532),0.04611957565923499,"['TMSB4X', 'DDIT4']",1
144,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.04656923035178603,['CD74'],1
145,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.04656923035178603,['DDIT4'],1
146,negative regulation of interleukin-8 production (GO:0032717),0.048292911255151554,['TMSB4X'],1
147,positive regulation of interleukin-4 production (GO:0032753),0.048292911255151554,['HLA-E'],1
148,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.048292911255151554,['CD74'],1
149,regulation of T cell cytokine production (GO:0002724),0.04961962699883498,['B2M'],1
150,negative regulation of nervous system development (GO:0051961),0.04961962699883498,['B2M'],1
151,positive regulation of neutrophil chemotaxis (GO:0090023),0.04961962699883498,['CD74'],1
152,prostaglandin biosynthetic process (GO:0001516),0.04961962699883498,['CD74'],1
0,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),4.056177465354193e-06,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",2
1,cytoplasmic translation (GO:0002181),4.056177465354193e-06,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",2
2,cotranslational protein targeting to membrane (GO:0006613),4.056177465354193e-06,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",2
3,protein targeting to ER (GO:0045047),4.824395942323014e-06,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",2
4,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",6.149757368207969e-06,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",2
5,antigen processing and presentation of endogenous peptide antigen (GO:0002483),2.075835383429735e-05,"['HLA-DRA', 'B2M', 'HLA-E']",2
6,peptide biosynthetic process (GO:0043043),2.651346263499792e-05,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",2
7,nuclear-transcribed mRNA catabolic process (GO:0000956),3.032944450555642e-05,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",2
8,translation (GO:0006412),8.15190984158129e-05,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",2
9,positive regulation of T cell mediated immunity (GO:0002711),0.00024091506002521792,"['HLA-DRA', 'B2M', 'HLA-E']",2
10,cellular macromolecule biosynthetic process (GO:0034645),0.0004324206914632178,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",2
11,gene expression (GO:0010467),0.0007258886374571986,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",2
12,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.0008216333077943834,"['B2M', 'HLA-E']",2
13,interferon-gamma-mediated signaling pathway (GO:0060333),0.0011430504026425684,"['HLA-DRA', 'B2M', 'HLA-E']",2
14,sequestering of actin monomers (GO:0042989),0.0011430504026425684,"['TMSB4X', 'TMSB10']",2
15,cellular protein metabolic process (GO:0044267),0.0011599573224752842,"['RPS8', 'RPL11', 'RPS6', 'RPS11', 'RPL19']",2
16,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.0033634340588045153,"['CD74', 'HLA-DRA', 'HLA-E']",2
17,positive regulation of alpha-beta T cell activation (GO:0046635),0.0039978374414207036,"['HLA-DRA', 'HLA-E']",2
18,cellular response to interferon-gamma (GO:0071346),0.004844517655625386,"['HLA-DRA', 'B2M', 'HLA-E']",2
19,negative regulation of actin filament polymerization (GO:0030837),0.0055749844187833525,"['TMSB4X', 'TMSB10']",2
20,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.0055749844187833525,"['CD74', 'TPT1']",2
21,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.0055749844187833525,"['HLA-DRA', 'HLA-E']",2
22,regulation of T cell mediated cytotoxicity (GO:0001914),0.006649677580675513,"['HLA-DRA', 'HLA-E']",2
23,negative regulation of response to DNA damage stimulus (GO:2001021),0.007289935890371812,"['CD74', 'TPT1']",2
24,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.007631715723842814,"['B2M', 'HLA-E']",2
25,positive regulation of cytokine production involved in immune response (GO:0002720),0.007631715723842814,"['B2M', 'HLA-E']",2
26,rRNA metabolic process (GO:0016072),0.008021192330621423,"['RPL11', 'RPS6', 'RPL19']",2
27,retina homeostasis (GO:0001895),0.00844041045557364,"['B2M', 'ACTG1']",2
28,regulation of cell migration (GO:0030334),0.008740707987258393,"['CD74', 'TMSB4X', 'TMSB10', 'ACTG1']",2
29,rRNA processing (GO:0006364),0.008740707987258393,"['RPL11', 'RPS6', 'RPL19']",2
30,regulation of immune response (GO:0050776),0.009339446819772883,"['HLA-DRA', 'B2M', 'HLA-E']",2
31,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.01054138462446233,"['HLA-DRA', 'HLA-E']",2
32,ribosome biogenesis (GO:0042254),0.01075010788304791,"['RPL11', 'RPS6', 'RPL19']",2
33,ncRNA processing (GO:0034470),0.011910992822433969,"['RPL11', 'RPS6', 'RPL19']",2
34,positive regulation of protein binding (GO:0032092),0.017484903908341457,"['RPL11', 'B2M']",2
35,ribonucleoprotein complex biogenesis (GO:0022613),0.018180638908410807,"['RPL11', 'RPS6']",2
36,protein tetramerization (GO:0051262),0.02467193914976852,"['B2M', 'MS4A1']",2
37,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.025374677831777933,"['B2M', 'HLA-E']",2
38,positive regulation of immune response (GO:0050778),0.02542388766475268,"['CD74', 'HLA-DRA']",2
39,positive regulation of lymphocyte proliferation (GO:0050671),0.02542388766475268,"['CD74', 'HLA-E']",2
40,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.02679358313489366,"['B2M', 'HLA-E']",2
41,regulation of interleukin-8 production (GO:0032677),0.028118156496156854,"['CD74', 'TMSB4X']",2
42,cytokine-mediated signaling pathway (GO:0019221),0.028118156496156854,"['TMSB4X', 'HLA-DRA', 'B2M', 'HLA-E']",2
43,innate immune response (GO:0045087),0.029420092283025306,"['CD74', 'B2M', 'HLA-E']",2
44,positive regulation of binding (GO:0051099),0.03232448248186749,"['RPL11', 'B2M']",2
45,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.03724347408275035,"['CD74', 'HLA-DRA']",2
46,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.03724347408275035,"['CD74', 'HLA-DRA']",2
47,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",0.03724347408275035,['HLA-DRA'],2
48,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026),0.03724347408275035,['TMSB4X'],2
49,positive regulation of natural killer cell proliferation (GO:0032819),0.03724347408275035,['HLA-E'],2
50,cellular response to nicotine (GO:0071316),0.03724347408275035,['B2M'],2
51,positive regulation of prostaglandin biosynthetic process (GO:0031394),0.03724347408275035,['CD74'],2
52,tight junction organization (GO:0120193),0.03724347408275035,['ACTG1'],2
53,regulation of natural killer cell mediated immunity (GO:0002715),0.03724347408275035,['HLA-E'],2
54,calcium ion transport (GO:0006816),0.038533401991162425,"['MS4A1', 'TPT1']",2
55,regulation of T-helper cell differentiation (GO:0045622),0.038533401991162425,['HLA-DRA'],2
56,regulation of type 2 immune response (GO:0002828),0.038533401991162425,['CD74'],2
57,cellular response to iron ion (GO:0071281),0.038533401991162425,['B2M'],2
58,positive regulation of receptor binding (GO:1900122),0.038533401991162425,['B2M'],2
59,peptide antigen assembly with MHC protein complex (GO:0002501),0.038533401991162425,['HLA-DRA'],2
60,protection from natural killer cell mediated cytotoxicity (GO:0042270),0.038533401991162425,['HLA-E'],2
61,regulation of protein binding (GO:0043393),0.038533401991162425,"['RPL11', 'B2M']",2
62,positive regulation of macromolecule metabolic process (GO:0010604),0.038533401991162425,"['CD74', 'RPL11', 'ACTG1']",2
63,positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.038533401991162425,['CD74'],2
64,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.038533401991162425,['HLA-E'],2
65,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.038533401991162425,['HLA-E'],2
66,response to host defenses (GO:0052200),0.038533401991162425,['B2M'],2
67,positive regulation of natural killer cell cytokine production (GO:0002729),0.038533401991162425,['HLA-E'],2
68,positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),0.038533401991162425,['CD74'],2
69,regulation of natural killer cell cytokine production (GO:0002727),0.038533401991162425,['HLA-E'],2
70,regulation of natural killer cell proliferation (GO:0032817),0.038533401991162425,['HLA-E'],2
71,modulation by symbiont of host defense response (GO:0052031),0.038533401991162425,['B2M'],2
72,regulation of prostaglandin biosynthetic process (GO:0031392),0.038533401991162425,['CD74'],2
73,regulation of cell motility (GO:2000145),0.03966990957091606,"['TMSB4X', 'TMSB10']",2
74,"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.03966990957091606,['HLA-DRA'],2
75,alpha-beta T cell activation (GO:0046631),0.03966990957091606,['HLA-E'],2
76,antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.03966990957091606,['B2M'],2
77,"regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.03966990957091606,['HLA-DRA'],2
78,"regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.03966990957091606,['HLA-E'],2
79,store-operated calcium entry (GO:0002115),0.03966990957091606,['MS4A1'],2
80,cytoplasmic sequestering of NF-kappaB (GO:0007253),0.03966990957091606,['TMSB4X'],2
81,regulation of intracellular signal transduction (GO:1902531),0.040146741322399135,"['TMSB4X', 'RPL11', 'DDIT4']",2
82,positive regulation of ATP biosynthetic process (GO:2001171),0.040146741322399135,['TMSB4X'],2
83,regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.040146741322399135,['TMSB4X'],2
84,"positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.040146741322399135,['HLA-E'],2
85,"regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.040146741322399135,['HLA-E'],2
86,positive regulation of ligase activity (GO:0051351),0.040146741322399135,['TMSB4X'],2
87,positive regulation of macrophage cytokine production (GO:0060907),0.040146741322399135,['CD74'],2
88,positive regulation of memory T cell differentiation (GO:0043382),0.040146741322399135,['HLA-DRA'],2
89,negative regulation of ubiquitin protein ligase activity (GO:1904667),0.040146741322399135,['RPL11'],2
90,regulation of receptor binding (GO:1900120),0.04053303830937007,['B2M'],2
91,immunoglobulin mediated immune response (GO:0016064),0.04053303830937007,['CD74'],2
92,positive regulation of monocyte differentiation (GO:0045657),0.04053303830937007,['CD74'],2
93,negative regulation of receptor binding (GO:1900121),0.04053303830937007,['B2M'],2
94,regulation of memory T cell differentiation (GO:0043380),0.04053303830937007,['HLA-DRA'],2
95,positive regulation of viral entry into host cell (GO:0046598),0.04053303830937007,['CD74'],2
96,modulation by symbiont of host process (GO:0044003),0.04053303830937007,['B2M'],2
97,positive regulation by symbiont of entry into host (GO:0075294),0.04053303830937007,['CD74'],2
98,regulation of protein neddylation (GO:2000434),0.04053303830937007,['RPL11'],2
99,B cell mediated immunity (GO:0019724),0.04325446294363687,['CD74'],2
100,positive regulation of interleukin-13 production (GO:0032736),0.04325446294363687,['HLA-E'],2
101,negative regulation of natural killer cell mediated immunity (GO:0002716),0.04325446294363687,['HLA-E'],2
102,positive regulation of gene expression (GO:0010628),0.044770588527761675,"['CD74', 'RPL11', 'ACTG1']",2
103,negative regulation of cell division (GO:0051782),0.044770588527761675,['TXNIP'],2
104,positive regulation of cellular senescence (GO:2000774),0.044770588527761675,['B2M'],2
105,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.044770588527761675,['HLA-DRA'],2
106,morphogenesis of a polarized epithelium (GO:0001738),0.044770588527761675,['ACTG1'],2
107,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.044770588527761675,['HLA-DRA'],2
108,positive regulation of cell aging (GO:0090343),0.044770588527761675,['B2M'],2
109,regulation of actomyosin structure organization (GO:0110020),0.044770588527761675,['ACTG1'],2
110,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.044770588527761675,['CD74'],2
111,response to iron ion (GO:0010039),0.044770588527761675,['B2M'],2
112,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.044770588527761675,['CD74'],2
113,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.044770588527761675,['BTG2'],2
114,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.044770588527761675,['TMSB4X'],2
115,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.044770588527761675,['CD74'],2
116,negative regulation of secretion (GO:0051048),0.044770588527761675,['CD74'],2
117,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.044770588527761675,['CD74'],2
118,positive regulation of regulatory T cell differentiation (GO:0045591),0.044770588527761675,['HLA-DRA'],2
119,regulation of macrophage cytokine production (GO:0010935),0.044770588527761675,['CD74'],2
120,cytoplasmic sequestering of transcription factor (GO:0042994),0.044770588527761675,['TMSB4X'],2
121,positive regulation of type 2 immune response (GO:0002830),0.044770588527761675,['CD74'],2
122,antigen receptor-mediated signaling pathway (GO:0050851),0.044770588527761675,"['HLA-DRA', 'MS4A1']",2
123,positive regulation of endothelial cell chemotaxis (GO:2001028),0.044770588527761675,['TMSB4X'],2
124,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.044770588527761675,['HLA-E'],2
125,calcium ion import into cytosol (GO:1902656),0.044770588527761675,['MS4A1'],2
126,regulation of endothelial cell chemotaxis (GO:2001026),0.044770588527761675,['TMSB4X'],2
127,positive regulation of natural killer cell activation (GO:0032816),0.044770588527761675,['HLA-E'],2
128,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.044770588527761675,['RPL11'],2
129,positive regulation of response to cytokine stimulus (GO:0060760),0.044770588527761675,['CD74'],2
130,neurotrophin TRK receptor signaling pathway (GO:0048011),0.044770588527761675,['DDIT4'],2
131,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.044770588527761675,['BTG2'],2
132,prostanoid biosynthetic process (GO:0046457),0.044770588527761675,['CD74'],2
133,protein localization to cell-cell junction (GO:0150105),0.044770588527761675,['ACTG1'],2
134,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.044770588527761675,['HLA-E'],2
135,regulation of ATP biosynthetic process (GO:2001169),0.044770588527761675,['TMSB4X'],2
136,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.044770588527761675,['HLA-E'],2
137,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.044770588527761675,['CD74'],2
138,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.044770588527761675,['TMSB4X'],2
139,regulation of interleukin-13 production (GO:0032656),0.044770588527761675,['HLA-E'],2
140,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.044770588527761675,['TPT1'],2
141,regulation of leukocyte activation (GO:0002694),0.044770588527761675,['CD74'],2
142,regulation of monocyte differentiation (GO:0045655),0.044770588527761675,['CD74'],2
143,negative regulation of intracellular signal transduction (GO:1902532),0.04611957565923499,"['TMSB4X', 'DDIT4']",2
144,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.04656923035178603,['CD74'],2
145,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.04656923035178603,['DDIT4'],2
146,negative regulation of interleukin-8 production (GO:0032717),0.048292911255151554,['TMSB4X'],2
147,positive regulation of interleukin-4 production (GO:0032753),0.048292911255151554,['HLA-E'],2
148,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.048292911255151554,['CD74'],2
149,regulation of T cell cytokine production (GO:0002724),0.04961962699883498,['B2M'],2
150,negative regulation of nervous system development (GO:0051961),0.04961962699883498,['B2M'],2
151,positive regulation of neutrophil chemotaxis (GO:0090023),0.04961962699883498,['CD74'],2
152,prostaglandin biosynthetic process (GO:0001516),0.04961962699883498,['CD74'],2
0,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),7.873316092284113e-17,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'RPL8', 'RPL29', 'RPS21', 'RPS12']",3
1,cotranslational protein targeting to membrane (GO:0006613),7.873316092284113e-17,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'RPL8', 'RPL29', 'RPS21', 'RPS12']",3
2,protein targeting to ER (GO:0045047),1.3640204938625834e-16,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'RPL8', 'RPL29', 'RPS21', 'RPS12']",3
3,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",2.6802473414236576e-16,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'RPL8', 'RPL29', 'RPS21', 'RPS12']",3
4,translation (GO:0006412),1.384248669407799e-15,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'EEF2', 'RPL8', 'RPL29', 'RPS21', 'RPS12']",3
5,cytoplasmic translation (GO:0002181),5.057763021357861e-15,"['RPS15', 'RPL3', 'RPLP1', 'RPL13A', 'RPS2', 'RPL8', 'RPL29', 'RPS21', 'RPS12']",3
6,peptide biosynthetic process (GO:0043043),6.234074320543146e-15,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'RPL8', 'RPL29', 'RPS21', 'RPS12']",3
7,nuclear-transcribed mRNA catabolic process (GO:0000956),9.471338825644101e-15,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'RPL8', 'RPL29', 'RPS21', 'RPS12']",3
8,cellular macromolecule biosynthetic process (GO:0034645),5.4464032231652364e-14,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'EEF2', 'RPL8', 'RPL29', 'RPS21', 'RPS12']",3
9,gene expression (GO:0010467),1.225383709411247e-11,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'RPL8', 'RPL29', 'RPS21', 'RPS12']",3
10,rRNA metabolic process (GO:0016072),4.529723875581664e-11,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'RPL8', 'RPL29']",3
11,cellular protein metabolic process (GO:0044267),4.919159686013722e-11,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'RPL8', 'RPL29', 'RPS21', 'RPS12']",3
12,rRNA processing (GO:0006364),6.51824751981287e-11,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'RPL8', 'RPL29']",3
13,ribosome biogenesis (GO:0042254),1.4018963263284606e-10,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'RPL8', 'RPL29']",3
14,ncRNA processing (GO:0034470),1.8911425100847957e-10,"['RPS15', 'RPL3', 'RPLP1', 'RPLP2', 'RPL13A', 'RPS2', 'RPL8', 'RPL29']",3
15,ribosome assembly (GO:0042255),0.01950559285347111,"['RPS15', 'RPL3']",3
0,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.00044667259654135425,"['CD74', 'MIF', 'TPT1']",4
1,negative regulation of response to DNA damage stimulus (GO:2001021),0.00044667259654135425,"['CD74', 'MIF', 'TPT1']",4
2,neutrophil degranulation (GO:0043312),0.00044667259654135425,"['TUBB', 'HLA-C', 'MIF', 'EEF2', 'B2M', 'FTL']",4
3,neutrophil activation involved in immune response (GO:0002283),0.00044667259654135425,"['TUBB', 'HLA-C', 'MIF', 'EEF2', 'B2M', 'FTL']",4
4,cellular response to interferon-gamma (GO:0071346),0.00044667259654135425,"['HLA-C', 'HLA-DRA', 'B2M', 'GAPDH']",4
5,neutrophil mediated immunity (GO:0002446),0.00044667259654135425,"['TUBB', 'HLA-C', 'MIF', 'EEF2', 'B2M', 'FTL']",4
6,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.0017114205305210196,"['HLA-C', 'B2M']",4
7,interferon-gamma-mediated signaling pathway (GO:0060333),0.0023229063679751083,"['HLA-C', 'HLA-DRA', 'B2M']",4
8,translation (GO:0006412),0.0026893388672828856,"['RPLP1', 'RPS6', 'EEF2', 'RPL8']",4
9,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.0026893388672828856,"['CD74', 'MIF']",4
10,antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.0026893388672828856,"['HLA-DRA', 'B2M']",4
11,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.0026893388672828856,"['CD74', 'MIF']",4
12,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.0026893388672828856,"['CD74', 'MIF']",4
13,positive regulation of gene expression (GO:0010628),0.0026893388672828856,"['CD74', 'MIF', 'EEF2', 'GAPDH', 'ACTG1']",4
14,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.0026893388672828856,"['RPLP1', 'RPS6', 'RPL8']",4
15,prostanoid biosynthetic process (GO:0046457),0.0026893388672828856,"['CD74', 'MIF']",4
16,cytoplasmic translation (GO:0002181),0.0026893388672828856,"['RPLP1', 'RPS6', 'RPL8']",4
17,cotranslational protein targeting to membrane (GO:0006613),0.0026893388672828856,"['RPLP1', 'RPS6', 'RPL8']",4
18,regulation of leukocyte activation (GO:0002694),0.0026893388672828856,"['CD74', 'MIF']",4
19,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.0028937880070599893,"['CD74', 'MIF']",4
20,protein targeting to ER (GO:0045047),0.0029577839141228415,"['RPLP1', 'RPS6', 'RPL8']",4
21,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.0029577839141228415,"['CD74', 'MIF']",4
22,prostaglandin biosynthetic process (GO:0001516),0.0031601364892513014,"['CD74', 'MIF']",4
23,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.003515172220796966,"['RPLP1', 'RPS6', 'RPL8']",4
24,cellular macromolecule biosynthetic process (GO:0034645),0.004126141336464396,"['RPLP1', 'RPS6', 'EEF2', 'RPL8']",4
25,cytoskeleton-dependent intracellular transport (GO:0030705),0.004126141336464396,"['TUBA1B', 'TUBB']",4
26,negative regulation of actin filament polymerization (GO:0030837),0.004705806316279503,"['TMSB4X', 'PFN1']",4
27,cytokine-mediated signaling pathway (GO:0019221),0.004743530851405978,"['TMSB4X', 'HLA-C', 'HLA-DRA', 'MIF', 'B2M']",4
28,regulation of actin filament bundle assembly (GO:0032231),0.004743530851405978,"['PFN1', 'ACTG1']",4
29,positive regulation of fibroblast proliferation (GO:0048146),0.005154969289705247,"['CD74', 'MIF']",4
30,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.005154969289705247,"['CD74', 'MIF']",4
31,transition metal ion homeostasis (GO:0055076),0.005360580655141334,"['B2M', 'FTL']",4
32,positive regulation of B cell proliferation (GO:0030890),0.005402389872868533,"['CD74', 'MIF']",4
33,regulation of macrophage activation (GO:0043030),0.005402389872868533,"['CD74', 'MIF']",4
34,prostaglandin metabolic process (GO:0006693),0.0056066093256826235,"['CD74', 'MIF']",4
35,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.006181963274510666,"['HLA-C', 'B2M']",4
36,rRNA metabolic process (GO:0016072),0.0063922313701778675,"['RPLP1', 'RPS6', 'RPL8']",4
37,peptide biosynthetic process (GO:0043043),0.0063922313701778675,"['RPLP1', 'RPS6', 'RPL8']",4
38,retina homeostasis (GO:0001895),0.006626664685219603,"['B2M', 'ACTG1']",4
39,positive regulation of T cell mediated immunity (GO:0002711),0.006626664685219603,"['HLA-DRA', 'B2M']",4
40,nuclear-transcribed mRNA catabolic process (GO:0000956),0.006839633002898252,"['RPLP1', 'RPS6', 'RPL8']",4
41,regulation of cell migration (GO:0030334),0.006839633002898252,"['CD74', 'TMSB4X', 'MIF', 'ACTG1']",4
42,rRNA processing (GO:0006364),0.006839633002898252,"['RPLP1', 'RPS6', 'RPL8']",4
43,regulation of immune response (GO:0050776),0.007380122312128222,"['HLA-C', 'HLA-DRA', 'B2M']",4
44,ribosome biogenesis (GO:0042254),0.008841941504468851,"['RPLP1', 'RPS6', 'RPL8']",4
45,regulation of B cell proliferation (GO:0030888),0.009209909317176372,"['CD74', 'MIF']",4
46,regulation of fibroblast proliferation (GO:0048145),0.009209909317176372,"['CD74', 'MIF']",4
47,ncRNA processing (GO:0034470),0.009462786274563957,"['RPLP1', 'RPS6', 'RPL8']",4
48,positive regulation of B cell activation (GO:0050871),0.01171238305922927,"['CD74', 'MIF']",4
49,iron ion homeostasis (GO:0055072),0.015170253197297033,"['B2M', 'FTL']",4
50,regulation of neurogenesis (GO:0050767),0.015359358762117007,"['HMGB2', 'B2M']",4
51,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.020738276064909925,"['HLA-C', 'B2M']",4
52,regulation of stress fiber assembly (GO:0051492),0.020738276064909925,"['PFN1', 'ACTG1']",4
53,positive regulation of immune response (GO:0050778),0.020738276064909925,"['CD74', 'HLA-DRA']",4
54,positive regulation of lymphocyte proliferation (GO:0050671),0.020738276064909925,"['CD74', 'MIF']",4
55,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.022001891291024873,"['HLA-C', 'B2M']",4
56,response to interferon-gamma (GO:0034341),0.02271879114847344,"['CD74', 'GAPDH']",4
57,regulation of interleukin-8 production (GO:0032677),0.022878637857753334,"['CD74', 'TMSB4X']",4
58,positive regulation of binding (GO:0051099),0.02765193143294717,"['HMGB2', 'B2M']",4
59,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.028385950633170086,"['CD74', 'MIF']",4
60,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.030832077227192285,"['CD74', 'HLA-DRA']",4
61,regulation of peptidyl-serine phosphorylation (GO:0033135),0.030832077227192285,"['DDIT4', 'MIF']",4
62,positive regulation of cytokine production (GO:0001819),0.030832077227192285,"['CD74', 'MIF', 'GAPDH']",4
63,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.030899714994111645,"['CD74', 'HLA-DRA']",4
64,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.030899714994111645,"['CD74', 'HLA-DRA']",4
65,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",0.030899714994111645,['HLA-DRA'],4
66,negative regulation of macrophage chemotaxis (GO:0010760),0.030899714994111645,['MIF'],4
67,intracellular sequestering of iron ion (GO:0006880),0.030899714994111645,['FTL'],4
68,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026),0.030899714994111645,['TMSB4X'],4
69,cellular response to nicotine (GO:0071316),0.030899714994111645,['B2M'],4
70,positive regulation of prostaglandin biosynthetic process (GO:0031394),0.030899714994111645,['CD74'],4
71,tight junction organization (GO:0120193),0.030899714994111645,['ACTG1'],4
72,peptidyl-cysteine S-nitrosylation (GO:0018119),0.030899714994111645,['GAPDH'],4
73,gene expression (GO:0010467),0.031099271410962304,"['RPLP1', 'RPS6', 'RPL8']",4
74,regulation of apoptotic process (GO:0042981),0.03299429599718069,"['CD74', 'RPS6', 'MIF', 'TPT1']",4
75,negative regulation of cell motility (GO:2000146),0.03299429599718069,"['CD74', 'MIF']",4
76,regulation of T-helper cell differentiation (GO:0045622),0.03299429599718069,['HLA-DRA'],4
77,regulation of type 2 immune response (GO:0002828),0.03299429599718069,['CD74'],4
78,cellular response to iron ion (GO:0071281),0.03299429599718069,['B2M'],4
79,positive regulation of receptor binding (GO:1900122),0.03299429599718069,['B2M'],4
80,peptide antigen assembly with MHC protein complex (GO:0002501),0.03299429599718069,['HLA-DRA'],4
81,regulation of nuclease activity (GO:0032069),0.03299429599718069,['HMGB2'],4
82,negative regulation of programmed cell death (GO:0043069),0.03347012533092606,"['CD74', 'MIF', 'TPT1']",4
83,protein homooligomerization (GO:0051260),0.03456085806541641,"['MIF', 'B2M']",4
84,positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.03466986971615072,['CD74'],4
85,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.03466986971615072,['HLA-C'],4
86,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.03466986971615072,['HLA-C'],4
87,response to host defenses (GO:0052200),0.03466986971615072,['B2M'],4
88,positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),0.03466986971615072,['CD74'],4
89,modulation by symbiont of host defense response (GO:0052031),0.03466986971615072,['B2M'],4
90,regulation of prostaglandin biosynthetic process (GO:0031392),0.03466986971615072,['CD74'],4
91,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.036775072902475794,"['CD74', 'MIF']",4
92,cellular protein metabolic process (GO:0044267),0.036775072902475794,"['RPLP1', 'RPS6', 'RPL8']",4
93,"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.036775072902475794,['HLA-DRA'],4
94,antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.036775072902475794,['B2M'],4
95,"regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.036775072902475794,['HLA-DRA'],4
96,negative regulation of macrophage migration (GO:1905522),0.036775072902475794,['MIF'],4
97,cytoplasmic sequestering of NF-kappaB (GO:0007253),0.036775072902475794,['TMSB4X'],4
98,positive regulation of ATP biosynthetic process (GO:2001171),0.03795309466696627,['TMSB4X'],4
99,regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.03795309466696627,['TMSB4X'],4
100,positive regulation of ligase activity (GO:0051351),0.03795309466696627,['TMSB4X'],4
101,positive regulation of macrophage cytokine production (GO:0060907),0.03795309466696627,['CD74'],4
102,positive regulation of megakaryocyte differentiation (GO:0045654),0.03795309466696627,['HMGB2'],4
103,positive regulation of memory T cell differentiation (GO:0043382),0.03795309466696627,['HLA-DRA'],4
104,positive regulation of protein kinase A signaling (GO:0010739),0.03795309466696627,['MIF'],4
105,DNA topological change (GO:0006265),0.03795309466696627,['HMGB2'],4
106,negative regulation of cell migration (GO:0030336),0.03795309466696627,"['CD74', 'MIF']",4
107,regulation of cytokine production (GO:0001817),0.03846731560873984,"['MIF', 'GAPDH']",4
108,regulation of receptor binding (GO:1900120),0.03846731560873984,['B2M'],4
109,immunoglobulin mediated immune response (GO:0016064),0.03846731560873984,['CD74'],4
110,positive regulation of monocyte differentiation (GO:0045657),0.03846731560873984,['CD74'],4
111,negative regulation of receptor binding (GO:1900121),0.03846731560873984,['B2M'],4
112,sequestering of actin monomers (GO:0042989),0.03846731560873984,['TMSB4X'],4
113,regulation of memory T cell differentiation (GO:0043380),0.03846731560873984,['HLA-DRA'],4
114,positive regulation of viral entry into host cell (GO:0046598),0.03846731560873984,['CD74'],4
115,modulation by symbiont of host process (GO:0044003),0.03846731560873984,['B2M'],4
116,positive regulation by symbiont of entry into host (GO:0075294),0.03846731560873984,['CD74'],4
117,B cell mediated immunity (GO:0019724),0.04158316324110003,['CD74'],4
118,V(D)J recombination (GO:0033151),0.04158316324110003,['HMGB2'],4
119,positive regulation of cell population proliferation (GO:0008284),0.042080753232262715,"['CD74', 'RPS6', 'MIF']",4
120,negative regulation of apoptotic process (GO:0043066),0.0428229482875486,"['CD74', 'MIF', 'TPT1']",4
121,positive regulation of cellular senescence (GO:2000774),0.0428229482875486,['B2M'],4
122,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.0428229482875486,['HLA-DRA'],4
123,negative regulation of leukocyte chemotaxis (GO:0002689),0.0428229482875486,['MIF'],4
124,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.0428229482875486,['PCBP1'],4
125,morphogenesis of a polarized epithelium (GO:0001738),0.0428229482875486,['ACTG1'],4
126,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.04296001081402963,"['CD74', 'GAPDH']",4
127,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.04296001081402963,"['CD74', 'MIF']",4
128,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.04296001081402963,['HLA-DRA'],4
129,positive regulation of cell aging (GO:0090343),0.04296001081402963,['B2M'],4
130,regulation of actomyosin structure organization (GO:0110020),0.04296001081402963,['ACTG1'],4
131,regulation of cell aging (GO:0090342),0.04296001081402963,['MIF'],4
132,response to iron ion (GO:0010039),0.04296001081402963,['B2M'],4
133,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.04296001081402963,['CD74'],4
134,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.04296001081402963,['TMSB4X'],4
135,positive regulation of ruffle assembly (GO:1900029),0.04296001081402963,['PFN1'],4
136,regulation of translation (GO:0006417),0.04397906822301156,"['EEF2', 'GAPDH']",4
137,protein stabilization (GO:0050821),0.04397906822301156,"['PFN1', 'GAPDH']",4
138,negative regulation of secretion (GO:0051048),0.04397906822301156,['CD74'],4
139,positive regulation of regulatory T cell differentiation (GO:0045591),0.04397906822301156,['HLA-DRA'],4
140,regulation of macrophage cytokine production (GO:0010935),0.04397906822301156,['CD74'],4
141,cytoplasmic sequestering of transcription factor (GO:0042994),0.04397906822301156,['TMSB4X'],4
142,positive regulation of type 2 immune response (GO:0002830),0.04397906822301156,['CD74'],4
143,protein trimerization (GO:0070206),0.0449001847505477,['MIF'],4
144,positive regulation of endothelial cell chemotaxis (GO:2001028),0.0449001847505477,['TMSB4X'],4
145,regulation of endothelial cell chemotaxis (GO:2001026),0.0449001847505477,['TMSB4X'],4
146,positive regulation of response to cytokine stimulus (GO:0060760),0.0449001847505477,['CD74'],4
147,neurotrophin TRK receptor signaling pathway (GO:0048011),0.0449001847505477,['DDIT4'],4
148,protein homotrimerization (GO:0070207),0.0449001847505477,['MIF'],4
149,protein localization to cell-cell junction (GO:0150105),0.0449001847505477,['ACTG1'],4
150,apoptotic DNA fragmentation (GO:0006309),0.04573646315184529,['HMGB2'],4
151,regulation of ATP biosynthetic process (GO:2001169),0.04573646315184529,['TMSB4X'],4
152,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.04573646315184529,['CD74'],4
153,killing by host of symbiont cells (GO:0051873),0.04573646315184529,['GAPDH'],4
154,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.04573646315184529,['TMSB4X'],4
155,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.04573646315184529,['TPT1'],4
156,regulation of monocyte differentiation (GO:0045655),0.04573646315184529,['CD74'],4
157,positive regulation of intracellular signal transduction (GO:1902533),0.04670110259085814,"['CD74', 'MIF', 'GAPDH']",4
158,negative regulation of intracellular signal transduction (GO:1902532),0.0468472453533762,"['TMSB4X', 'DDIT4']",4
159,negative regulation of cell aging (GO:0090344),0.047072828008685834,['MIF'],4
160,regulation of stem cell proliferation (GO:0072091),0.047072828008685834,['HMGB2'],4
161,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.047072828008685834,['DDIT4'],4
162,generation of neurons (GO:0048699),0.04745424419838775,"['DDIT4', 'HMGB2']",4
163,negative regulation of interleukin-8 production (GO:0032717),0.048912414274937165,['TMSB4X'],4
164,DNA conformation change (GO:0071103),0.048912414274937165,['HMGB2'],4
0,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",2.121098522008674e-08,"['HLA-C', 'HLA-A', 'B2M', 'HLA-E']",5
1,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),3.119215632860691e-06,"['HLA-C', 'HLA-A', 'B2M', 'HLA-E']",5
2,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),3.119215632860691e-06,"['HLA-C', 'HLA-A', 'HLA-E']",5
3,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",3.119215632860691e-06,"['HLA-C', 'HLA-A', 'HLA-E']",5
4,cellular response to interferon-gamma (GO:0071346),8.988673425895684e-06,"['HLA-C', 'HLA-A', 'B2M', 'GAPDH', 'HLA-E']",5
5,antigen processing and presentation of endogenous peptide antigen (GO:0002483),2.153099727726127e-05,"['HLA-A', 'B2M', 'HLA-E']",5
6,interferon-gamma-mediated signaling pathway (GO:0060333),3.392921690285863e-05,"['HLA-C', 'HLA-A', 'B2M', 'HLA-E']",5
7,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",3.9551456230654006e-05,"['HLA-C', 'HLA-A', 'B2M', 'HLA-E']",5
8,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),4.5926991614953304e-05,"['HLA-C', 'HLA-A', 'B2M', 'HLA-E']",5
9,cytokine-mediated signaling pathway (GO:0019221),5.9481704308726915e-05,"['TMSB4X', 'RPLP0', 'HLA-C', 'MIF', 'HLA-A', 'B2M', 'HLA-E']",5
10,glucose catabolic process to pyruvate (GO:0061718),5.9481704308726915e-05,"['TPI1', 'ALDOC', 'GAPDH']",5
11,canonical glycolysis (GO:0061621),5.9481704308726915e-05,"['TPI1', 'ALDOC', 'GAPDH']",5
12,glycolytic process through glucose-6-phosphate (GO:0061620),6.235371574924963e-05,"['TPI1', 'ALDOC', 'GAPDH']",5
13,glycolytic process (GO:0006096),9.175144320131878e-05,"['TPI1', 'ALDOC', 'GAPDH']",5
14,positive regulation of cytokine production involved in immune response (GO:0002720),0.00012754095145618604,"['HLA-A', 'B2M', 'HLA-E']",5
15,positive regulation of T cell mediated immunity (GO:0002711),0.00015617632613297317,"['HLA-A', 'B2M', 'HLA-E']",5
16,gluconeogenesis (GO:0006094),0.0002066040203357826,"['TPI1', 'ALDOC', 'GAPDH']",5
17,carbohydrate catabolic process (GO:0016052),0.0002066040203357826,"['TPI1', 'ALDOC', 'GAPDH']",5
18,hexose biosynthetic process (GO:0019319),0.00024271117096188766,"['TPI1', 'ALDOC', 'GAPDH']",5
19,protection from natural killer cell mediated cytotoxicity (GO:0042270),0.0002971080023399526,"['HLA-A', 'HLA-E']",5
20,pyruvate metabolic process (GO:0006090),0.0004319589764135642,"['TPI1', 'ALDOC', 'GAPDH']",5
21,alpha-beta T cell activation (GO:0046631),0.00044931141281554513,"['HLA-A', 'HLA-E']",5
22,antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.00044931141281554513,"['HLA-A', 'B2M']",5
23,"regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.00044931141281554513,"['HLA-A', 'HLA-E']",5
24,regulation of immune response (GO:0050776),0.00044931141281554513,"['HLA-C', 'HLA-A', 'B2M', 'HLA-E']",5
25,glucose metabolic process (GO:0006006),0.0005002358101334848,"['TPI1', 'ALDOC', 'GAPDH']",5
26,"positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.0005002358101334848,"['HLA-A', 'HLA-E']",5
27,"regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.0005002358101334848,"['HLA-A', 'HLA-E']",5
28,cellular response to type I interferon (GO:0071357),0.0005002358101334848,"['HLA-C', 'HLA-A', 'HLA-E']",5
29,type I interferon signaling pathway (GO:0060337),0.0005002358101334848,"['HLA-C', 'HLA-A', 'HLA-E']",5
30,defense response to Gram-positive bacterium (GO:0050830),0.000604745594743066,"['HMGB2', 'HLA-A', 'HLA-E']",5
31,translation (GO:0006412),0.0007050710710473591,"['RPLP1', 'RPLP0', 'RPS2', 'EEF2']",5
32,neutrophil degranulation (GO:0043312),0.0011261210166543104,"['HLA-C', 'ALDOC', 'MIF', 'EEF2', 'B2M']",5
33,neutrophil activation involved in immune response (GO:0002283),0.0011261210166543104,"['HLA-C', 'ALDOC', 'MIF', 'EEF2', 'B2M']",5
34,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.0011261210166543104,"['RPLP1', 'RPLP0', 'RPS2']",5
35,neutrophil mediated immunity (GO:0002446),0.0011261210166543104,"['HLA-C', 'ALDOC', 'MIF', 'EEF2', 'B2M']",5
36,cytoplasmic translation (GO:0002181),0.001181345646236763,"['RPLP1', 'RPLP0', 'RPS2']",5
37,cotranslational protein targeting to membrane (GO:0006613),0.001181345646236763,"['RPLP1', 'RPLP0', 'RPS2']",5
38,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.001181345646236763,"['HLA-A', 'HLA-E']",5
39,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.001181345646236763,"['HLA-A', 'HLA-E']",5
40,protein targeting to ER (GO:0045047),0.0014465025977041025,"['RPLP1', 'RPLP0', 'RPS2']",5
41,regulation of T cell cytokine production (GO:0002724),0.0016003767492447332,"['HLA-A', 'B2M']",5
42,positive regulation of alpha-beta T cell activation (GO:0046635),0.001735802926265184,"['HLA-A', 'HLA-E']",5
43,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.0017731399697825405,"['RPLP1', 'RPLP0', 'RPS2']",5
44,positive regulation of T cell cytokine production (GO:0002726),0.0018321536673810371,"['HLA-A', 'B2M']",5
45,cellular macromolecule biosynthetic process (GO:0034645),0.002151275374116173,"['RPLP1', 'RPLP0', 'RPS2', 'EEF2']",5
46,positive regulation of cytokine production (GO:0001819),0.0025962200189968967,"['MIF', 'HLA-A', 'GAPDH', 'HLA-E']",5
47,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.0025962200189968967,"['MIF', 'TPT1']",5
48,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.0025962200189968967,"['HLA-A', 'HLA-E']",5
49,regulation of T cell mediated cytotoxicity (GO:0001914),0.003172704727573915,"['HLA-A', 'HLA-E']",5
50,negative regulation of response to DNA damage stimulus (GO:2001021),0.0035582463315433272,"['MIF', 'TPT1']",5
51,rRNA metabolic process (GO:0016072),0.00423836212572655,"['RPLP1', 'RPLP0', 'RPS2']",5
52,peptide biosynthetic process (GO:0043043),0.00423836212572655,"['RPLP1', 'RPLP0', 'RPS2']",5
53,nuclear-transcribed mRNA catabolic process (GO:0000956),0.004869226503136547,"['RPLP1', 'RPLP0', 'RPS2']",5
54,rRNA processing (GO:0006364),0.004945115188821126,"['RPLP1', 'RPLP0', 'RPS2']",5
55,defense response to bacterium (GO:0042742),0.0051056383181267324,"['HMGB2', 'HLA-A', 'HLA-E']",5
56,regulation of translation (GO:0006417),0.005183410908060317,"['BTG2', 'EEF2', 'GAPDH']",5
57,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.006032410402019686,"['HLA-A', 'HLA-E']",5
58,antibacterial humoral response (GO:0019731),0.006132629782413683,"['HLA-A', 'HLA-E']",5
59,ribosome biogenesis (GO:0042254),0.006132629782413683,"['RPLP1', 'RPLP0', 'RPS2']",5
60,interleukin-12-mediated signaling pathway (GO:0035722),0.006562377718165059,"['RPLP0', 'MIF']",5
61,positive regulation of neuron death (GO:1901216),0.0066579370177959,"['DDIT4', 'CDK5R1']",5
62,ncRNA processing (GO:0034470),0.0066579370177959,"['RPLP1', 'RPLP0', 'RPS2']",5
63,generation of neurons (GO:0048699),0.0066579370177959,"['DDIT4', 'HMGB2', 'CDK5R1']",5
64,cellular response to interleukin-12 (GO:0071349),0.006703879635228373,"['RPLP0', 'MIF']",5
65,neuron migration (GO:0001764),0.007161473704656059,"['DDIT4', 'CDK5R1']",5
66,regulation of neurogenesis (GO:0050767),0.010812006673187501,"['HMGB2', 'B2M']",5
67,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.011629613963031332,"['BTG2', 'HMGB2', 'GAPDH', 'CDK5R1']",5
68,positive regulation of lymphocyte proliferation (GO:0050671),0.015287064471344081,"['MIF', 'HLA-E']",5
69,positive regulation of tumor necrosis factor production (GO:0032760),0.01586962667925321,"['MIF', 'HLA-E']",5
70,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.01728373726235111,"['MIF', 'HLA-E']",5
71,negative regulation of cellular amide metabolic process (GO:0034249),0.019169323827677616,"['BTG2', 'GAPDH']",5
72,positive regulation of binding (GO:0051099),0.020388421818923193,"['HMGB2', 'B2M']",5
73,negative regulation of translation (GO:0017148),0.020388421818923193,"['BTG2', 'GAPDH']",5
74,negative regulation of gene expression (GO:0010629),0.02143832214860158,"['BTG2', 'MIF', 'GAPDH']",5
75,negative regulation of cellular protein metabolic process (GO:0032269),0.021614295058594475,"['BTG2', 'GAPDH']",5
76,regulation of peptidyl-serine phosphorylation (GO:0033135),0.023142600362671958,"['DDIT4', 'MIF']",5
77,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.02483338346318802,"['HLA-A', 'HLA-E']",5
78,negative regulation of macrophage chemotaxis (GO:0010760),0.02483338346318802,['MIF'],5
79,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026),0.02483338346318802,['TMSB4X'],5
80,positive regulation of natural killer cell proliferation (GO:0032819),0.02483338346318802,['HLA-E'],5
81,cellular response to nicotine (GO:0071316),0.02483338346318802,['B2M'],5
82,regulation of natural killer cell mediated immunity (GO:0002715),0.02483338346318802,['HLA-E'],5
83,peptidyl-cysteine S-nitrosylation (GO:0018119),0.02483338346318802,['GAPDH'],5
84,gene expression (GO:0010467),0.02503807036137132,"['RPLP1', 'RPLP0', 'RPS2']",5
85,regulation of macroautophagy (GO:0016241),0.026872808892631477,"['GAPDH', 'CDK5R1']",5
86,cellular response to iron ion (GO:0071281),0.028112570587634625,['B2M'],5
87,positive regulation of receptor binding (GO:1900122),0.028112570587634625,['B2M'],5
88,regulation of nuclease activity (GO:0032069),0.028112570587634625,['HMGB2'],5
89,protein homooligomerization (GO:0051260),0.029771819222118048,"['MIF', 'B2M']",5
90,regulation of tumor necrosis factor production (GO:0032680),0.029771819222118048,"['MIF', 'HLA-E']",5
91,aldehyde biosynthetic process (GO:0046184),0.029771819222118048,['TPI1'],5
92,glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.029771819222118048,['TPI1'],5
93,response to host defenses (GO:0052200),0.029771819222118048,['B2M'],5
94,positive regulation of natural killer cell cytokine production (GO:0002729),0.029771819222118048,['HLA-E'],5
95,regulation of natural killer cell cytokine production (GO:0002727),0.029771819222118048,['HLA-E'],5
96,regulation of natural killer cell proliferation (GO:0032817),0.029771819222118048,['HLA-E'],5
97,modulation by symbiont of host defense response (GO:0052031),0.029771819222118048,['B2M'],5
98,plasma membrane bounded cell projection organization (GO:0120036),0.030234138965543153,"['BTG2', 'CDK5R1']",5
99,cellular protein metabolic process (GO:0044267),0.03204675983613466,"['RPLP1', 'RPLP0', 'RPS2']",5
100,fructose metabolic process (GO:0006000),0.03204675983613466,['ALDOC'],5
101,negative regulation of macrophage migration (GO:1905522),0.03204675983613466,['MIF'],5
102,T cell mediated cytotoxicity (GO:0001913),0.03204675983613466,['HLA-A'],5
103,cytoplasmic sequestering of NF-kappaB (GO:0007253),0.03204675983613466,['TMSB4X'],5
104,neuron development (GO:0048666),0.03287450281983056,"['BTG2', 'CDK5R1']",5
105,regulation of intracellular signal transduction (GO:1902531),0.03287450281983056,"['TMSB4X', 'DDIT4', 'CDK5R1']",5
106,positive regulation of ATP biosynthetic process (GO:2001171),0.03287450281983056,['TMSB4X'],5
107,regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.03287450281983056,['TMSB4X'],5
108,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.03287450281983056,['ALDOC'],5
109,positive regulation of ligase activity (GO:0051351),0.03287450281983056,['TMSB4X'],5
110,positive regulation of megakaryocyte differentiation (GO:0045654),0.03287450281983056,['HMGB2'],5
111,ketone biosynthetic process (GO:0042181),0.03287450281983056,['TPI1'],5
112,positive regulation of protein kinase A signaling (GO:0010739),0.03287450281983056,['MIF'],5
113,DNA topological change (GO:0006265),0.03287450281983056,['HMGB2'],5
114,brain development (GO:0007420),0.03411581563109369,"['DDIT4', 'CDK5R1']",5
115,regulation of cytokine production (GO:0001817),0.03411581563109369,"['MIF', 'GAPDH']",5
116,regulation of receptor binding (GO:1900120),0.03411581563109369,['B2M'],5
117,negative regulation of receptor binding (GO:1900121),0.03411581563109369,['B2M'],5
118,sequestering of actin monomers (GO:0042989),0.03411581563109369,['TMSB4X'],5
119,ionotropic glutamate receptor signaling pathway (GO:0035235),0.03411581563109369,['CDK5R1'],5
120,neuron projection fasciculation (GO:0106030),0.03411581563109369,['CDK5R1'],5
121,modulation by symbiont of host process (GO:0044003),0.03411581563109369,['B2M'],5
122,glycerol metabolic process (GO:0006071),0.03631882472852223,['TPI1'],5
123,positive regulation of interleukin-13 production (GO:0032736),0.03631882472852223,['HLA-E'],5
124,negative regulation of natural killer cell mediated immunity (GO:0002716),0.03631882472852223,['HLA-E'],5
125,V(D)J recombination (GO:0033151),0.03631882472852223,['HMGB2'],5
126,positive regulation of gene expression (GO:0010628),0.03838323758353659,"['MIF', 'EEF2', 'GAPDH']",5
127,positive regulation of cellular senescence (GO:2000774),0.03838323758353659,['B2M'],5
128,axonal fasciculation (GO:0007413),0.03838323758353659,['CDK5R1'],5
129,negative regulation of leukocyte chemotaxis (GO:0002689),0.03838323758353659,['MIF'],5
130,neuron projection development (GO:0031175),0.03915273013267853,"['BTG2', 'CDK5R1']",5
131,neuron differentiation (GO:0030182),0.03915273013267853,"['DDIT4', 'CDK5R1']",5
132,positive regulation of cell aging (GO:0090343),0.03915273013267853,['B2M'],5
133,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.03915273013267853,['MIF'],5
134,regulation of cell aging (GO:0090342),0.03915273013267853,['MIF'],5
135,response to iron ion (GO:0010039),0.03915273013267853,['B2M'],5
136,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.03915273013267853,['BTG2'],5
137,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.03915273013267853,['TMSB4X'],5
138,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.040957323070582904,['MIF'],5
139,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.040957323070582904,['MIF'],5
140,cytoplasmic sequestering of transcription factor (GO:0042994),0.040957323070582904,['TMSB4X'],5
141,detection of bacterium (GO:0016045),0.040957323070582904,['HLA-A'],5
142,protein trimerization (GO:0070206),0.04097638541947108,['MIF'],5
143,positive regulation of endothelial cell chemotaxis (GO:2001028),0.04097638541947108,['TMSB4X'],5
144,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.04097638541947108,['HLA-E'],5
145,regulation of endothelial cell chemotaxis (GO:2001026),0.04097638541947108,['TMSB4X'],5
146,positive regulation of natural killer cell activation (GO:0032816),0.04097638541947108,['HLA-E'],5
147,neurotrophin TRK receptor signaling pathway (GO:0048011),0.04097638541947108,['DDIT4'],5
148,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.04097638541947108,['BTG2'],5
149,prostanoid biosynthetic process (GO:0046457),0.04097638541947108,['MIF'],5
150,protein homotrimerization (GO:0070207),0.04097638541947108,['MIF'],5
151,endoderm development (GO:0007492),0.04097638541947108,['DUSP2'],5
152,apoptotic DNA fragmentation (GO:0006309),0.041245274704597906,['HMGB2'],5
153,regulation of ATP biosynthetic process (GO:2001169),0.041245274704597906,['TMSB4X'],5
154,killing by host of symbiont cells (GO:0051873),0.041245274704597906,['GAPDH'],5
155,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.041245274704597906,['TMSB4X'],5
156,regulation of interleukin-13 production (GO:0032656),0.041245274704597906,['HLA-E'],5
157,neuron cell-cell adhesion (GO:0007158),0.041245274704597906,['CDK5R1'],5
158,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.041245274704597906,['TPT1'],5
159,T cell mediated immunity (GO:0002456),0.041245274704597906,['HLA-A'],5
160,regulation of leukocyte activation (GO:0002694),0.041245274704597906,['MIF'],5
161,negative regulation of intracellular signal transduction (GO:1902532),0.04248298887722798,"['TMSB4X', 'DDIT4']",5
162,negative regulation of cell aging (GO:0090344),0.04248298887722798,['MIF'],5
163,regulation of stem cell proliferation (GO:0072091),0.04248298887722798,['HMGB2'],5
164,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.04248298887722798,['MIF'],5
165,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.04248298887722798,['DDIT4'],5
166,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.04364603338692771,['CDK5R1'],5
167,negative regulation of interleukin-8 production (GO:0032717),0.04364603338692771,['TMSB4X'],5
168,positive regulation of interleukin-4 production (GO:0032753),0.04364603338692771,['HLA-E'],5
169,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.04364603338692771,['MIF'],5
170,DNA conformation change (GO:0071103),0.04364603338692771,['HMGB2'],5
171,negative regulation of nervous system development (GO:0051961),0.045516625669953556,['B2M'],5
172,prostaglandin biosynthetic process (GO:0001516),0.045516625669953556,['MIF'],5
173,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.04734222912903439,['HLA-E'],5
174,regulation of protein kinase A signaling (GO:0010738),0.04734222912903439,['MIF'],5
175,acetylcholine receptor signaling pathway (GO:0095500),0.04830563126997801,['CDK5R1'],5
176,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.04830563126997801,['DDIT4'],5
177,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.04830563126997801,['DDIT4'],5
178,neuron apoptotic process (GO:0051402),0.04830563126997801,['GAPDH'],5
179,neurotrophin signaling pathway (GO:0038179),0.04830563126997801,['DDIT4'],5
0,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),4.3935471984622725e-10,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",6
1,cytoplasmic translation (GO:0002181),4.3935471984622725e-10,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",6
2,cotranslational protein targeting to membrane (GO:0006613),4.3935471984622725e-10,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",6
3,protein targeting to ER (GO:0045047),6.34583202581829e-10,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",6
4,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",9.839193166051855e-10,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",6
5,peptide biosynthetic process (GO:0043043),1.0517918021935191e-08,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",6
6,nuclear-transcribed mRNA catabolic process (GO:0000956),1.318741532911936e-08,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",6
7,translation (GO:0006412),5.551047375411666e-08,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",6
8,cellular macromolecule biosynthetic process (GO:0034645),7.042409693182933e-07,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",6
9,gene expression (GO:0010467),1.5016978776166618e-06,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",6
10,cellular protein metabolic process (GO:0044267),4.022626743942083e-06,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",6
11,rRNA metabolic process (GO:0016072),1.7001291900564215e-05,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18']",6
12,rRNA processing (GO:0006364),2.1732690229560337e-05,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18']",6
13,ribosome biogenesis (GO:0042254),3.377151533094736e-05,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18']",6
14,ncRNA processing (GO:0034470),3.950348785979325e-05,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18']",6
15,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.0007338378132115158,"['HLA-C', 'B2M']",6
16,iron ion homeostasis (GO:0055072),0.0007728242648752619,"['MYC', 'B2M', 'FTL']",6
17,modulation by symbiont of host process (GO:0044003),0.001047087114083246,"['ENO1', 'B2M']",6
18,regulation of monocyte differentiation (GO:0045655),0.0026357900845272527,"['CD74', 'MYC']",6
19,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.004368897531009685,"['DDIT4', 'RACK1']",6
20,cellular response to interferon-gamma (GO:0071346),0.004818185644263131,"['HLA-C', 'B2M', 'GAPDH']",6
21,glucose catabolic process to pyruvate (GO:0061718),0.004984060236511861,"['ENO1', 'GAPDH']",6
22,canonical glycolysis (GO:0061621),0.004984060236511861,"['ENO1', 'GAPDH']",6
23,glycolytic process through glucose-6-phosphate (GO:0061620),0.005188619962114596,"['ENO1', 'GAPDH']",6
24,positive regulation of fibroblast proliferation (GO:0048146),0.006226777398171382,"['CD74', 'MYC']",6
25,glycolytic process (GO:0006096),0.006226777398171382,"['ENO1', 'GAPDH']",6
26,transition metal ion homeostasis (GO:0055076),0.006226777398171382,"['B2M', 'FTL']",6
27,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.0064294244836556455,"['RPS16', 'RPS21']",6
28,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.007521357209482462,"['HLA-C', 'B2M']",6
29,ribosomal small subunit biogenesis (GO:0042274),0.010215950650917741,"['RPS15', 'RPS16']",6
30,gluconeogenesis (GO:0006094),0.010215950650917741,"['ENO1', 'GAPDH']",6
31,response to growth factor (GO:0070848),0.010215950650917741,"['MYC', 'RACK1']",6
32,carbohydrate catabolic process (GO:0016052),0.010215950650917741,"['ENO1', 'GAPDH']",6
33,hexose biosynthetic process (GO:0019319),0.011418541718137274,"['ENO1', 'GAPDH']",6
34,regulation of fibroblast proliferation (GO:0048145),0.011784631384767038,"['CD74', 'MYC']",6
35,positive regulation of response to stimulus (GO:0048584),0.011784631384767038,"['MYC', 'B2M']",6
36,ribosome assembly (GO:0042255),0.013538547017763731,"['RPS15', 'RPL3']",6
37,neutrophil degranulation (GO:0043312),0.013739489568967261,"['TUBB', 'HLA-C', 'B2M', 'FTL']",6
38,neutrophil activation involved in immune response (GO:0002283),0.013769309189037316,"['TUBB', 'HLA-C', 'B2M', 'FTL']",6
39,neutrophil mediated immunity (GO:0002446),0.013769309189037316,"['TUBB', 'HLA-C', 'B2M', 'FTL']",6
40,pyruvate metabolic process (GO:0006090),0.01476657837944265,"['ENO1', 'GAPDH']",6
41,ribosomal large subunit biogenesis (GO:0042273),0.015288937237696497,"['RPL7A', 'RPL3']",6
42,apoptotic process (GO:0006915),0.015288937237696497,"['MYC', 'DDIT4', 'GAPDH']",6
43,cellular iron ion homeostasis (GO:0006879),0.015288937237696497,"['MYC', 'FTL']",6
44,ribonucleoprotein complex biogenesis (GO:0022613),0.015988135059902705,"['RPS15', 'RPS16']",6
45,positive regulation of DNA biosynthetic process (GO:2000573),0.016161076775689173,"['MYC', 'HNRNPA1']",6
46,glucose metabolic process (GO:0006006),0.016334682381496397,"['ENO1', 'GAPDH']",6
47,positive regulation of intracellular signal transduction (GO:1902533),0.017344149221669092,"['RPS15', 'CD74', 'RACK1', 'GAPDH']",6
48,interferon-gamma-mediated signaling pathway (GO:0060333),0.018806793995648108,"['HLA-C', 'B2M']",6
49,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.020937208839365028,"['HLA-C', 'B2M']",6
50,regulation of cytokine-mediated signaling pathway (GO:0001959),0.020937208839365028,"['CD74', 'RACK1']",6
51,negative regulation of protein binding (GO:0032091),0.020937208839365028,"['RACK1', 'B2M']",6
52,regulation of cell division (GO:0051302),0.021649443879940035,"['MYC', 'RACK1']",6
53,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.02236245981431273,"['HLA-C', 'B2M']",6
54,response to interferon-gamma (GO:0034341),0.023076114050285715,"['CD74', 'GAPDH']",6
55,negative regulation of cellular amide metabolic process (GO:0034249),0.026120332912149914,"['RACK1', 'GAPDH']",6
56,negative regulation of translation (GO:0017148),0.028052264084107284,"['RACK1', 'GAPDH']",6
57,regulation of epithelial cell proliferation (GO:0050678),0.029395023745532673,"['MYC', 'B2M']",6
58,negative regulation of cellular protein metabolic process (GO:0032269),0.02950734271481465,"['RACK1', 'GAPDH']",6
59,cellular transition metal ion homeostasis (GO:0046916),0.030233991149053372,"['MYC', 'FTL']",6
60,regulation of peptidyl-serine phosphorylation (GO:0033135),0.030959967094325167,"['DDIT4', 'RACK1']",6
61,negative regulation of hydrogen peroxide-induced neuron death (GO:1903208),0.031137538426853312,['RACK1'],6
62,rescue of stalled ribosome (GO:0072344),0.031137538426853312,['RACK1'],6
63,positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.031137538426853312,['RACK1'],6
64,response to sodium arsenite (GO:1903935),0.031137538426853312,['HNRNPA1'],6
65,positive regulation of mitochondrial depolarization (GO:0051901),0.031137538426853312,['RACK1'],6
66,intracellular sequestering of iron ion (GO:0006880),0.031137538426853312,['FTL'],6
67,cellular response to nicotine (GO:0071316),0.031137538426853312,['B2M'],6
68,cellular response to sodium arsenite (GO:1903936),0.031137538426853312,['HNRNPA1'],6
69,positive regulation of prostaglandin biosynthetic process (GO:0031394),0.031137538426853312,['CD74'],6
70,peptidyl-cysteine S-nitrosylation (GO:0018119),0.031137538426853312,['GAPDH'],6
71,protein-DNA complex subunit organization (GO:0071824),0.03254882295917987,['MYC'],6
72,negative regulation of cellular response to hypoxia (GO:1900038),0.03254882295917987,['ENO1'],6
73,regulation of type 2 immune response (GO:0002828),0.03254882295917987,['CD74'],6
74,positive regulation of kidney development (GO:0090184),0.03254882295917987,['MYC'],6
75,cellular response to iron ion (GO:0071281),0.03254882295917987,['B2M'],6
76,cellular response to salt (GO:1902075),0.03254882295917987,['HNRNPA1'],6
77,positive regulation of plasminogen activation (GO:0010756),0.03254882295917987,['ENO1'],6
78,positive regulation of receptor binding (GO:1900122),0.03254882295917987,['B2M'],6
79,regulation of protein binding (GO:0043393),0.03254882295917987,"['RACK1', 'B2M']",6
80,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.03254882295917987,"['MYC', 'RACK1']",6
81,negative regulation of cell growth (GO:0030308),0.03254882295917987,"['RACK1', 'ENO1']",6
82,negative regulation of growth (GO:0045926),0.03254882295917987,"['RACK1', 'ENO1']",6
83,positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.03254882295917987,['CD74'],6
84,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.03254882295917987,['HLA-C'],6
85,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.03254882295917987,['HLA-C'],6
86,positive regulation of gastrulation (GO:2000543),0.03254882295917987,['RACK1'],6
87,response to host defenses (GO:0052200),0.03254882295917987,['B2M'],6
88,ribosomal small subunit export from nucleus (GO:0000056),0.03254882295917987,['RPS15'],6
89,positive regulation of membrane depolarization (GO:1904181),0.03254882295917987,['RACK1'],6
90,negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.03254882295917987,['MYC'],6
91,positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),0.03254882295917987,['CD74'],6
92,oxygen transport (GO:0015671),0.03254882295917987,['MYC'],6
93,modulation by symbiont of host defense response (GO:0052031),0.03254882295917987,['B2M'],6
94,regulation of prostaglandin biosynthetic process (GO:0031392),0.03254882295917987,['CD74'],6
95,antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.03530393546204878,['B2M'],6
96,regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),0.03530393546204878,['RACK1'],6
97,positive regulation of muscle contraction (GO:0045933),0.03530393546204878,['ENO1'],6
98,regulation of Golgi to plasma membrane protein transport (GO:0042996),0.03530393546204878,['RACK1'],6
99,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.03530393546204878,['RPS21'],6
100,ribonucleoprotein complex assembly (GO:0022618),0.03530393546204878,"['RPS15', 'RPL3']",6
101,positive regulation of ATP biosynthetic process (GO:2001171),0.03806158344643068,['ENO1'],6
102,positive regulation of macrophage cytokine production (GO:0060907),0.03806158344643068,['CD74'],6
103,positive regulation of transferase activity (GO:0051347),0.03806158344643068,"['CD74', 'MYC']",6
104,positive regulation of hydrolase activity (GO:0051345),0.03806158344643068,"['RGS1', 'RACK1']",6
105,regulation of receptor binding (GO:1900120),0.03806158344643068,['B2M'],6
106,immunoglobulin mediated immune response (GO:0016064),0.03806158344643068,['CD74'],6
107,regulation of DNA methylation (GO:0044030),0.03806158344643068,['MYC'],6
108,positive regulation of mesenchymal cell proliferation (GO:0002053),0.03806158344643068,['MYC'],6
109,rRNA 3'-end processing (GO:0031125),0.03806158344643068,['RPS21'],6
110,regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.03806158344643068,['RACK1'],6
111,positive regulation of monocyte differentiation (GO:0045657),0.03806158344643068,['CD74'],6
112,negative regulation of receptor binding (GO:1900121),0.03806158344643068,['B2M'],6
113,positive regulation of viral entry into host cell (GO:0046598),0.03806158344643068,['CD74'],6
114,positive regulation by symbiont of entry into host (GO:0075294),0.03806158344643068,['CD74'],6
115,negative regulation of protein phosphorylation (GO:0001933),0.03806158344643068,"['DDIT4', 'RACK1']",6
116,positive regulation of ceramide biosynthetic process (GO:2000304),0.03975300334725574,['RACK1'],6
117,B cell mediated immunity (GO:0019724),0.03975300334725574,['CD74'],6
118,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.03975300334725574,['RACK1'],6
119,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.03975300334725574,['RACK1'],6
120,regulation of mesenchymal cell proliferation (GO:0010464),0.03975300334725574,['MYC'],6
121,regulation of mitochondrial depolarization (GO:0051900),0.03975300334725574,['RACK1'],6
122,positive regulation of gene expression (GO:0010628),0.041639804325733186,"['CD74', 'MYC', 'GAPDH']",6
123,negative regulation of cell division (GO:0051782),0.041639804325733186,['MYC'],6
124,positive regulation of cellular senescence (GO:2000774),0.041639804325733186,['B2M'],6
125,gas transport (GO:0015669),0.041639804325733186,['MYC'],6
126,regulation of plasminogen activation (GO:0010755),0.041639804325733186,['ENO1'],6
127,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.04179727943162032,"['CD74', 'GAPDH']",6
128,positive regulation of cell aging (GO:0090343),0.04179727943162032,['B2M'],6
129,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.04179727943162032,['RACK1'],6
130,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.04179727943162032,['RACK1'],6
131,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.04179727943162032,['CD74'],6
132,response to iron ion (GO:0010039),0.04179727943162032,['B2M'],6
133,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.04179727943162032,['CD74'],6
134,ribosomal subunit export from nucleus (GO:0000054),0.04179727943162032,['RPS15'],6
135,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.04179727943162032,['ENO1'],6
136,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.04179727943162032,['RPS21'],6
137,regulation of translation (GO:0006417),0.042217692945501865,"['RACK1', 'GAPDH']",6
138,regulation of immune response (GO:0050776),0.042217692945501865,"['HLA-C', 'B2M']",6
139,antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.042217692945501865,['B2M'],6
140,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.042217692945501865,['CD74'],6
141,negative regulation of secretion (GO:0051048),0.042217692945501865,['CD74'],6
142,regulation of gastrulation (GO:0010470),0.042217692945501865,['RACK1'],6
143,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.042217692945501865,['CD74'],6
144,regulation of macrophage cytokine production (GO:0010935),0.042217692945501865,['CD74'],6
145,positive regulation of type 2 immune response (GO:0002830),0.042217692945501865,['CD74'],6
146,cellular response to arsenic-containing substance (GO:0071243),0.04400615452321379,['HNRNPA1'],6
147,positive regulation of response to cytokine stimulus (GO:0060760),0.04400615452321379,['CD74'],6
148,neurotrophin TRK receptor signaling pathway (GO:0048011),0.04400615452321379,['DDIT4'],6
149,prostanoid biosynthetic process (GO:0046457),0.04400615452321379,['CD74'],6
150,regulation of GTPase activity (GO:0043087),0.0442778045003752,"['RGS1', 'RACK1']",6
151,regulation of ATP biosynthetic process (GO:2001169),0.04482578136342359,['ENO1'],6
152,regulation of ceramide biosynthetic process (GO:2000303),0.04482578136342359,['RACK1'],6
153,regulation of establishment of cell polarity (GO:2000114),0.04482578136342359,['RACK1'],6
154,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.04482578136342359,['CD74'],6
155,killing by host of symbiont cells (GO:0051873),0.04482578136342359,['GAPDH'],6
156,regulation of leukocyte activation (GO:0002694),0.04482578136342359,['CD74'],6
157,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.04585249708007149,"['RACK1', 'ENO1', 'GAPDH']",6
158,negative regulation of intracellular signal transduction (GO:1902532),0.04585249708007149,"['DDIT4', 'RACK1']",6
159,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.04585249708007149,['CD74'],6
160,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.04585249708007149,['DDIT4'],6
161,ribosomal small subunit assembly (GO:0000028),0.04585249708007149,['RPS15'],6
162,negative regulation of phagocytosis (GO:0050765),0.04585249708007149,['RACK1'],6
163,negative regulation of fibroblast proliferation (GO:0048147),0.04763948120865268,['MYC'],6
164,regulation of establishment or maintenance of cell polarity (GO:0032878),0.04763948120865268,['RACK1'],6
165,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.04763948120865268,['CD74'],6
166,negative regulation of cellular process (GO:0048523),0.04763948120865268,"['MYC', 'RACK1', 'ENO1']",6
167,mitotic cell cycle phase transition (GO:0044772),0.04768761004401328,"['TUBB', 'MYC']",6
168,regulation of stem cell population maintenance (GO:2000036),0.04768761004401328,['MYC'],6
169,regulation of T cell cytokine production (GO:0002724),0.04768761004401328,['B2M'],6
170,branching involved in ureteric bud morphogenesis (GO:0001658),0.04768761004401328,['MYC'],6
171,negative regulation of nervous system development (GO:0051961),0.04768761004401328,['B2M'],6
172,positive regulation of neutrophil chemotaxis (GO:0090023),0.04768761004401328,['CD74'],6
173,ureteric bud morphogenesis (GO:0060675),0.04768761004401328,['MYC'],6
174,prostaglandin biosynthetic process (GO:0001516),0.04768761004401328,['CD74'],6
175,positive regulation of GTPase activity (GO:0043547),0.0477195536877001,"['RGS1', 'RACK1']",6
176,positive regulation of protein modification process (GO:0031401),0.0477195536877001,"['CD74', 'RACK1']",6
177,regulation of cell growth (GO:0001558),0.0477195536877001,"['RACK1', 'ENO1']",6
178,protein-DNA complex disassembly (GO:0032986),0.0477195536877001,['MYC'],6
179,positive regulation of embryonic development (GO:0040019),0.0477195536877001,['RACK1'],6
180,negative regulation of telomere maintenance via telomerase (GO:0032211),0.0477195536877001,['HNRNPA1'],6
181,positive regulation of protein processing (GO:0010954),0.0477195536877001,['ENO1'],6
182,natural killer cell mediated immunity (GO:0002228),0.0477195536877001,['TUBB'],6
183,energy reserve metabolic process (GO:0006112),0.0477195536877001,['MYC'],6
184,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.048756880046936096,"['CD74', 'GAPDH']",6
185,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.048756880046936096,['DDIT4'],6
186,neuron apoptotic process (GO:0051402),0.048756880046936096,['GAPDH'],6
187,neurotrophin signaling pathway (GO:0038179),0.048756880046936096,['DDIT4'],6
188,positive regulation of T cell cytokine production (GO:0002726),0.048756880046936096,['B2M'],6
189,regulation of vacuole organization (GO:0044088),0.04923106874495602,['ENO1'],6
190,positive regulation of granulocyte chemotaxis (GO:0071624),0.04923106874495602,['CD74'],6
191,regulation of chromosome organization (GO:0033044),0.04923106874495602,['MYC'],6
192,positive regulation of neutrophil migration (GO:1902624),0.04923106874495602,['CD74'],6
193,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.04923106874495602,['RPS21'],6
194,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.04923106874495602,['RPS15'],6
195,natural killer cell mediated cytotoxicity (GO:0042267),0.04923106874495602,['TUBB'],6
0,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),4.3935471984622725e-10,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",7
1,cytoplasmic translation (GO:0002181),4.3935471984622725e-10,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",7
2,cotranslational protein targeting to membrane (GO:0006613),4.3935471984622725e-10,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",7
3,protein targeting to ER (GO:0045047),6.34583202581829e-10,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",7
4,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",9.839193166051855e-10,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",7
5,peptide biosynthetic process (GO:0043043),1.0517918021935191e-08,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",7
6,nuclear-transcribed mRNA catabolic process (GO:0000956),1.318741532911936e-08,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",7
7,translation (GO:0006412),5.551047375411666e-08,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",7
8,cellular macromolecule biosynthetic process (GO:0034645),7.042409693182933e-07,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",7
9,gene expression (GO:0010467),1.5016978776166618e-06,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",7
10,cellular protein metabolic process (GO:0044267),4.022626743942083e-06,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18', 'RPS11', 'RPS21']",7
11,rRNA metabolic process (GO:0016072),1.7001291900564215e-05,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18']",7
12,rRNA processing (GO:0006364),2.1732690229560337e-05,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18']",7
13,ribosome biogenesis (GO:0042254),3.377151533094736e-05,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18']",7
14,ncRNA processing (GO:0034470),3.950348785979325e-05,"['RPS15', 'RPL7A', 'RPL3', 'RPS16', 'RPL18']",7
15,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.0007338378132115158,"['HLA-C', 'B2M']",7
16,iron ion homeostasis (GO:0055072),0.0007728242648752619,"['MYC', 'B2M', 'FTL']",7
17,modulation by symbiont of host process (GO:0044003),0.001047087114083246,"['ENO1', 'B2M']",7
18,regulation of monocyte differentiation (GO:0045655),0.0026357900845272527,"['CD74', 'MYC']",7
19,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.004368897531009685,"['DDIT4', 'RACK1']",7
20,cellular response to interferon-gamma (GO:0071346),0.004818185644263131,"['HLA-C', 'B2M', 'GAPDH']",7
21,glucose catabolic process to pyruvate (GO:0061718),0.004984060236511861,"['ENO1', 'GAPDH']",7
22,canonical glycolysis (GO:0061621),0.004984060236511861,"['ENO1', 'GAPDH']",7
23,glycolytic process through glucose-6-phosphate (GO:0061620),0.005188619962114596,"['ENO1', 'GAPDH']",7
24,positive regulation of fibroblast proliferation (GO:0048146),0.006226777398171382,"['CD74', 'MYC']",7
25,glycolytic process (GO:0006096),0.006226777398171382,"['ENO1', 'GAPDH']",7
26,transition metal ion homeostasis (GO:0055076),0.006226777398171382,"['B2M', 'FTL']",7
27,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.0064294244836556455,"['RPS16', 'RPS21']",7
28,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.007521357209482462,"['HLA-C', 'B2M']",7
29,ribosomal small subunit biogenesis (GO:0042274),0.010215950650917741,"['RPS15', 'RPS16']",7
30,gluconeogenesis (GO:0006094),0.010215950650917741,"['ENO1', 'GAPDH']",7
31,response to growth factor (GO:0070848),0.010215950650917741,"['MYC', 'RACK1']",7
32,carbohydrate catabolic process (GO:0016052),0.010215950650917741,"['ENO1', 'GAPDH']",7
33,hexose biosynthetic process (GO:0019319),0.011418541718137274,"['ENO1', 'GAPDH']",7
34,regulation of fibroblast proliferation (GO:0048145),0.011784631384767038,"['CD74', 'MYC']",7
35,positive regulation of response to stimulus (GO:0048584),0.011784631384767038,"['MYC', 'B2M']",7
36,ribosome assembly (GO:0042255),0.013538547017763731,"['RPS15', 'RPL3']",7
37,neutrophil degranulation (GO:0043312),0.013739489568967261,"['TUBB', 'HLA-C', 'B2M', 'FTL']",7
38,neutrophil activation involved in immune response (GO:0002283),0.013769309189037316,"['TUBB', 'HLA-C', 'B2M', 'FTL']",7
39,neutrophil mediated immunity (GO:0002446),0.013769309189037316,"['TUBB', 'HLA-C', 'B2M', 'FTL']",7
40,pyruvate metabolic process (GO:0006090),0.01476657837944265,"['ENO1', 'GAPDH']",7
41,ribosomal large subunit biogenesis (GO:0042273),0.015288937237696497,"['RPL7A', 'RPL3']",7
42,apoptotic process (GO:0006915),0.015288937237696497,"['MYC', 'DDIT4', 'GAPDH']",7
43,cellular iron ion homeostasis (GO:0006879),0.015288937237696497,"['MYC', 'FTL']",7
44,ribonucleoprotein complex biogenesis (GO:0022613),0.015988135059902705,"['RPS15', 'RPS16']",7
45,positive regulation of DNA biosynthetic process (GO:2000573),0.016161076775689173,"['MYC', 'HNRNPA1']",7
46,glucose metabolic process (GO:0006006),0.016334682381496397,"['ENO1', 'GAPDH']",7
47,positive regulation of intracellular signal transduction (GO:1902533),0.017344149221669092,"['RPS15', 'CD74', 'RACK1', 'GAPDH']",7
48,interferon-gamma-mediated signaling pathway (GO:0060333),0.018806793995648108,"['HLA-C', 'B2M']",7
49,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.020937208839365028,"['HLA-C', 'B2M']",7
50,regulation of cytokine-mediated signaling pathway (GO:0001959),0.020937208839365028,"['CD74', 'RACK1']",7
51,negative regulation of protein binding (GO:0032091),0.020937208839365028,"['RACK1', 'B2M']",7
52,regulation of cell division (GO:0051302),0.021649443879940035,"['MYC', 'RACK1']",7
53,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.02236245981431273,"['HLA-C', 'B2M']",7
54,response to interferon-gamma (GO:0034341),0.023076114050285715,"['CD74', 'GAPDH']",7
55,negative regulation of cellular amide metabolic process (GO:0034249),0.026120332912149914,"['RACK1', 'GAPDH']",7
56,negative regulation of translation (GO:0017148),0.028052264084107284,"['RACK1', 'GAPDH']",7
57,regulation of epithelial cell proliferation (GO:0050678),0.029395023745532673,"['MYC', 'B2M']",7
58,negative regulation of cellular protein metabolic process (GO:0032269),0.02950734271481465,"['RACK1', 'GAPDH']",7
59,cellular transition metal ion homeostasis (GO:0046916),0.030233991149053372,"['MYC', 'FTL']",7
60,regulation of peptidyl-serine phosphorylation (GO:0033135),0.030959967094325167,"['DDIT4', 'RACK1']",7
61,negative regulation of hydrogen peroxide-induced neuron death (GO:1903208),0.031137538426853312,['RACK1'],7
62,rescue of stalled ribosome (GO:0072344),0.031137538426853312,['RACK1'],7
63,positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.031137538426853312,['RACK1'],7
64,response to sodium arsenite (GO:1903935),0.031137538426853312,['HNRNPA1'],7
65,positive regulation of mitochondrial depolarization (GO:0051901),0.031137538426853312,['RACK1'],7
66,intracellular sequestering of iron ion (GO:0006880),0.031137538426853312,['FTL'],7
67,cellular response to nicotine (GO:0071316),0.031137538426853312,['B2M'],7
68,cellular response to sodium arsenite (GO:1903936),0.031137538426853312,['HNRNPA1'],7
69,positive regulation of prostaglandin biosynthetic process (GO:0031394),0.031137538426853312,['CD74'],7
70,peptidyl-cysteine S-nitrosylation (GO:0018119),0.031137538426853312,['GAPDH'],7
71,protein-DNA complex subunit organization (GO:0071824),0.03254882295917987,['MYC'],7
72,negative regulation of cellular response to hypoxia (GO:1900038),0.03254882295917987,['ENO1'],7
73,regulation of type 2 immune response (GO:0002828),0.03254882295917987,['CD74'],7
74,positive regulation of kidney development (GO:0090184),0.03254882295917987,['MYC'],7
75,cellular response to iron ion (GO:0071281),0.03254882295917987,['B2M'],7
76,cellular response to salt (GO:1902075),0.03254882295917987,['HNRNPA1'],7
77,positive regulation of plasminogen activation (GO:0010756),0.03254882295917987,['ENO1'],7
78,positive regulation of receptor binding (GO:1900122),0.03254882295917987,['B2M'],7
79,regulation of protein binding (GO:0043393),0.03254882295917987,"['RACK1', 'B2M']",7
80,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.03254882295917987,"['MYC', 'RACK1']",7
81,negative regulation of cell growth (GO:0030308),0.03254882295917987,"['RACK1', 'ENO1']",7
82,negative regulation of growth (GO:0045926),0.03254882295917987,"['RACK1', 'ENO1']",7
83,positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.03254882295917987,['CD74'],7
84,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.03254882295917987,['HLA-C'],7
85,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.03254882295917987,['HLA-C'],7
86,positive regulation of gastrulation (GO:2000543),0.03254882295917987,['RACK1'],7
87,response to host defenses (GO:0052200),0.03254882295917987,['B2M'],7
88,ribosomal small subunit export from nucleus (GO:0000056),0.03254882295917987,['RPS15'],7
89,positive regulation of membrane depolarization (GO:1904181),0.03254882295917987,['RACK1'],7
90,negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.03254882295917987,['MYC'],7
91,positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),0.03254882295917987,['CD74'],7
92,oxygen transport (GO:0015671),0.03254882295917987,['MYC'],7
93,modulation by symbiont of host defense response (GO:0052031),0.03254882295917987,['B2M'],7
94,regulation of prostaglandin biosynthetic process (GO:0031392),0.03254882295917987,['CD74'],7
95,antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.03530393546204878,['B2M'],7
96,regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),0.03530393546204878,['RACK1'],7
97,positive regulation of muscle contraction (GO:0045933),0.03530393546204878,['ENO1'],7
98,regulation of Golgi to plasma membrane protein transport (GO:0042996),0.03530393546204878,['RACK1'],7
99,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.03530393546204878,['RPS21'],7
100,ribonucleoprotein complex assembly (GO:0022618),0.03530393546204878,"['RPS15', 'RPL3']",7
101,positive regulation of ATP biosynthetic process (GO:2001171),0.03806158344643068,['ENO1'],7
102,positive regulation of macrophage cytokine production (GO:0060907),0.03806158344643068,['CD74'],7
103,positive regulation of transferase activity (GO:0051347),0.03806158344643068,"['CD74', 'MYC']",7
104,positive regulation of hydrolase activity (GO:0051345),0.03806158344643068,"['RGS1', 'RACK1']",7
105,regulation of receptor binding (GO:1900120),0.03806158344643068,['B2M'],7
106,immunoglobulin mediated immune response (GO:0016064),0.03806158344643068,['CD74'],7
107,regulation of DNA methylation (GO:0044030),0.03806158344643068,['MYC'],7
108,positive regulation of mesenchymal cell proliferation (GO:0002053),0.03806158344643068,['MYC'],7
109,rRNA 3'-end processing (GO:0031125),0.03806158344643068,['RPS21'],7
110,regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.03806158344643068,['RACK1'],7
111,positive regulation of monocyte differentiation (GO:0045657),0.03806158344643068,['CD74'],7
112,negative regulation of receptor binding (GO:1900121),0.03806158344643068,['B2M'],7
113,positive regulation of viral entry into host cell (GO:0046598),0.03806158344643068,['CD74'],7
114,positive regulation by symbiont of entry into host (GO:0075294),0.03806158344643068,['CD74'],7
115,negative regulation of protein phosphorylation (GO:0001933),0.03806158344643068,"['DDIT4', 'RACK1']",7
116,positive regulation of ceramide biosynthetic process (GO:2000304),0.03975300334725574,['RACK1'],7
117,B cell mediated immunity (GO:0019724),0.03975300334725574,['CD74'],7
118,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.03975300334725574,['RACK1'],7
119,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.03975300334725574,['RACK1'],7
120,regulation of mesenchymal cell proliferation (GO:0010464),0.03975300334725574,['MYC'],7
121,regulation of mitochondrial depolarization (GO:0051900),0.03975300334725574,['RACK1'],7
122,positive regulation of gene expression (GO:0010628),0.041639804325733186,"['CD74', 'MYC', 'GAPDH']",7
123,negative regulation of cell division (GO:0051782),0.041639804325733186,['MYC'],7
124,positive regulation of cellular senescence (GO:2000774),0.041639804325733186,['B2M'],7
125,gas transport (GO:0015669),0.041639804325733186,['MYC'],7
126,regulation of plasminogen activation (GO:0010755),0.041639804325733186,['ENO1'],7
127,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.04179727943162032,"['CD74', 'GAPDH']",7
128,positive regulation of cell aging (GO:0090343),0.04179727943162032,['B2M'],7
129,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.04179727943162032,['RACK1'],7
130,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.04179727943162032,['RACK1'],7
131,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.04179727943162032,['CD74'],7
132,response to iron ion (GO:0010039),0.04179727943162032,['B2M'],7
133,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.04179727943162032,['CD74'],7
134,ribosomal subunit export from nucleus (GO:0000054),0.04179727943162032,['RPS15'],7
135,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.04179727943162032,['ENO1'],7
136,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.04179727943162032,['RPS21'],7
137,regulation of translation (GO:0006417),0.042217692945501865,"['RACK1', 'GAPDH']",7
138,regulation of immune response (GO:0050776),0.042217692945501865,"['HLA-C', 'B2M']",7
139,antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.042217692945501865,['B2M'],7
140,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.042217692945501865,['CD74'],7
141,negative regulation of secretion (GO:0051048),0.042217692945501865,['CD74'],7
142,regulation of gastrulation (GO:0010470),0.042217692945501865,['RACK1'],7
143,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.042217692945501865,['CD74'],7
144,regulation of macrophage cytokine production (GO:0010935),0.042217692945501865,['CD74'],7
145,positive regulation of type 2 immune response (GO:0002830),0.042217692945501865,['CD74'],7
146,cellular response to arsenic-containing substance (GO:0071243),0.04400615452321379,['HNRNPA1'],7
147,positive regulation of response to cytokine stimulus (GO:0060760),0.04400615452321379,['CD74'],7
148,neurotrophin TRK receptor signaling pathway (GO:0048011),0.04400615452321379,['DDIT4'],7
149,prostanoid biosynthetic process (GO:0046457),0.04400615452321379,['CD74'],7
150,regulation of GTPase activity (GO:0043087),0.0442778045003752,"['RGS1', 'RACK1']",7
151,regulation of ATP biosynthetic process (GO:2001169),0.04482578136342359,['ENO1'],7
152,regulation of ceramide biosynthetic process (GO:2000303),0.04482578136342359,['RACK1'],7
153,regulation of establishment of cell polarity (GO:2000114),0.04482578136342359,['RACK1'],7
154,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.04482578136342359,['CD74'],7
155,killing by host of symbiont cells (GO:0051873),0.04482578136342359,['GAPDH'],7
156,regulation of leukocyte activation (GO:0002694),0.04482578136342359,['CD74'],7
157,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.04585249708007149,"['RACK1', 'ENO1', 'GAPDH']",7
158,negative regulation of intracellular signal transduction (GO:1902532),0.04585249708007149,"['DDIT4', 'RACK1']",7
159,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.04585249708007149,['CD74'],7
160,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.04585249708007149,['DDIT4'],7
161,ribosomal small subunit assembly (GO:0000028),0.04585249708007149,['RPS15'],7
162,negative regulation of phagocytosis (GO:0050765),0.04585249708007149,['RACK1'],7
163,negative regulation of fibroblast proliferation (GO:0048147),0.04763948120865268,['MYC'],7
164,regulation of establishment or maintenance of cell polarity (GO:0032878),0.04763948120865268,['RACK1'],7
165,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.04763948120865268,['CD74'],7
166,negative regulation of cellular process (GO:0048523),0.04763948120865268,"['MYC', 'RACK1', 'ENO1']",7
167,mitotic cell cycle phase transition (GO:0044772),0.04768761004401328,"['TUBB', 'MYC']",7
168,regulation of stem cell population maintenance (GO:2000036),0.04768761004401328,['MYC'],7
169,regulation of T cell cytokine production (GO:0002724),0.04768761004401328,['B2M'],7
170,branching involved in ureteric bud morphogenesis (GO:0001658),0.04768761004401328,['MYC'],7
171,negative regulation of nervous system development (GO:0051961),0.04768761004401328,['B2M'],7
172,positive regulation of neutrophil chemotaxis (GO:0090023),0.04768761004401328,['CD74'],7
173,ureteric bud morphogenesis (GO:0060675),0.04768761004401328,['MYC'],7
174,prostaglandin biosynthetic process (GO:0001516),0.04768761004401328,['CD74'],7
175,positive regulation of GTPase activity (GO:0043547),0.0477195536877001,"['RGS1', 'RACK1']",7
176,positive regulation of protein modification process (GO:0031401),0.0477195536877001,"['CD74', 'RACK1']",7
177,regulation of cell growth (GO:0001558),0.0477195536877001,"['RACK1', 'ENO1']",7
178,protein-DNA complex disassembly (GO:0032986),0.0477195536877001,['MYC'],7
179,positive regulation of embryonic development (GO:0040019),0.0477195536877001,['RACK1'],7
180,negative regulation of telomere maintenance via telomerase (GO:0032211),0.0477195536877001,['HNRNPA1'],7
181,positive regulation of protein processing (GO:0010954),0.0477195536877001,['ENO1'],7
182,natural killer cell mediated immunity (GO:0002228),0.0477195536877001,['TUBB'],7
183,energy reserve metabolic process (GO:0006112),0.0477195536877001,['MYC'],7
184,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.048756880046936096,"['CD74', 'GAPDH']",7
185,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.048756880046936096,['DDIT4'],7
186,neuron apoptotic process (GO:0051402),0.048756880046936096,['GAPDH'],7
187,neurotrophin signaling pathway (GO:0038179),0.048756880046936096,['DDIT4'],7
188,positive regulation of T cell cytokine production (GO:0002726),0.048756880046936096,['B2M'],7
189,regulation of vacuole organization (GO:0044088),0.04923106874495602,['ENO1'],7
190,positive regulation of granulocyte chemotaxis (GO:0071624),0.04923106874495602,['CD74'],7
191,regulation of chromosome organization (GO:0033044),0.04923106874495602,['MYC'],7
192,positive regulation of neutrophil migration (GO:1902624),0.04923106874495602,['CD74'],7
193,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.04923106874495602,['RPS21'],7
194,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.04923106874495602,['RPS15'],7
195,natural killer cell mediated cytotoxicity (GO:0042267),0.04923106874495602,['TUBB'],7
